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The national drugs and alcohol strategy Reducing 
harm, supporting recovery: a health-led response 
to drug and alcohol use in Ireland 2017‒20251 
follows through on the commitment made by the 
Government in May 2016 to pursue a health-led 
rather than a criminal justice approach to drug 
use.2 Seeing drug use as a health issue rather 
than a criminal one is an important step towards 
reducing the stigma experienced by people who 
use drugs. Activities that aim to raise awareness 
of the issue and set out to reduce the stigma are 
ongoing in Ireland.
UISCE and the Press Ombudsman
In October 2017, the Press Ombudsman of Ireland issued an 
advisory notice3 to all national and local newspaper editors.  
The letter was sent following an approach made to 
the Ombudsman by the Union for Improved Services, 
Communication and Education (UISCE). In their submission, 
UISCE made a number of key points that are echoed in 
the report by the Global Commission on Drug Policy which 
is covered in the next article and explores the negative 
perceptions of drugs and the people who use them.4 
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In brief
Reducing harm, supporting recovery: a health-led 
response to drug and alcohol use in Ireland 2017—
2025 underlined the shift in Irish drugs policy over 
the last few years towards a health-led approach. 
It was made very clear at the launch of the strategy 
last year and in most official commentary around it 
that the Irish government viewed drugs as a public 
health rather than a criminal justice issue. 
The impact of this change in emphasis, typical of policy 
development in the European Union in recent years, can 
be understood in a number of ways. First of all, we can 
see it as a consolidation of the generally humane view of 
those at most risk from harm due to their use of drugs 
and a recognition that a just society must commit to 
providing high-quality services and support to all, no matter 
where they are from or how their need has arisen. So the 
individually focused values of compassion and respect both 
support, and are supported by, the social values of equity 
and inclusion. While human rights are only specifically 
mentioned once in the strategy, a human rights approach 
is very evident in the sections dealing with supervised 
injecting facilities and alternatives to punishment.
The emphasis on increasing wellbeing rather than imposing 
sanctions is also pragmatic. There is a recognition that 
employing law enforcement as the State’s most effective 
response to drug use is counterproductive. It criminalises 
those whose drug use may be experimental or short-lived 
and may undermine the capacity or motivation of those in 
greatest need of professional help to access services. In this 
issue, we look at the recent Pompidou Group of the Council 
of Europe report on the unintended consequences of 
drug control policies, including the use of more hazardous 
substances, riskier use of drugs, physical danger as a result 
of involvement in illicit markets, and the stigma that results 
from using prohibited substances. The issue of stigma is 
considered in two further articles in this issue, and the 
mental and physical consequences associated with it 
exacerbate the already difficult situation faced by many 
people who use drugs.
Good policy depends on evidence, particularly reliable 
data, being available to make decisions, identify current 
harms and future risks, and plan responses. Administrative 
data are a very valuable research resource, but they 
have shortcomings when compared with data that are 
collected and analysed using a monitoring system created 
for that purpose. Criminological researchers, while adept 
at gathering and analysing behavioural information, often 
have to depend on administrative data that have not 
being collected with this type of analysis in mind. Criminal 
activity associated with or a consequence of drug use can 
be difficult to measure and monitor. Taking a public health 
perspective enables researchers of these activities to avail 
of well-established information systems that often contain 
highly relevant data. It also presents an opportunity to learn 
from a highly successful, well-established and scientific 
approach to information gathering. 
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Those cited in the Ombudsman’s advisory notice include: 
• Stigma is a barrier to equality. The language and imagery 
used to describe addiction in the media contributes to 
the stigma experienced by people who use drugs.
• There is a ‘widely-held, generalising, and unscientific 
position’ that illicit drugs are ‘bad’ and this informs a 
perception that people who use drugs are bad too.
• Drug use is viewed as unacceptable and criminal and 
therefore people who use drugs are labelled as ‘deviant 
criminals’.
• Stigma leads to discrimination and they are ‘what drive 
the gross violations of the human rights of people who 
use drugs, and also result in these violations going for the 
most part unchallenged’.
 
UISCE provides a sample list of stigmatising language and 
offers alternatives that it advocates using.5 
CityWide campaign
On behalf of CityWide Drugs Crisis Campaign, on 27 February 
2018, the Minister of State for Health Promotion and the 
National Drugs Strategy, Catherine Byrne TD, launched a new 
campaign that focuses specifically on the issue of stigma 
called ‘Stop the Stigma: Addiction is a health issue not a 
crime’.6 Its overall aim is to challenge drug-related stigma. 
CityWide believes that stigma will have a negative impact on 
the effective implementation of many of the actions in the 
national drugs strategy. Stigma is identified by CityWide and its 
partners as presenting a barrier to people who want to address 
their problem drug use; it drives people into isolation, danger 
and back into addiction. They argue that it labels families and 
neighbourhoods. It destroys people’s prospects and their 
chance to contribute to society. CityWide see this as bad news 
for everyone; for people who have problems with addiction, 
for their families and their wider communities, and for people 
who work in addiction and related public services
The first stage of the campaign is about increasing awareness  
of stigma and its impact, as well as building up alliances 
through a wide range of non-governmental organisations and 
civil society networks. 
Lucy Dillon
1 Department of Health (2017) Reducing harm, supporting 
recovery: a health-led response to drug and alcohol use  
in Ireland 2017—2025. Dublin: Department of Health.  
http://www.drugsandalcohol.ie/27603/ 
2 Government of Ireland (2016) A programme for a partnership 
government. Dublin: Department of the Taoiseach.  
http://www.drugsandalcohol.ie/25508/
3 See UISCE’s 2017 newsletter Brass Munkie, especially pages 
8 and 9, which include the full advisory notice from the Press 
Ombudsman: http://www.drugsandalcohol.ie/28378/
4  Global Commission on Drug Policy (2018) The world drug 
perception problem: countering prejudices about people  
who use drugs. Geneva: Global Commission on Drug Policy. 
https://www.drugsandalcohol.ie/28434/
5 The full list is available at: http://www.drugsandalcohol.ie/28473/  
6 The campaign messages and materials can be accessed at:  
http://www.citywide.ie. 
Reducing stigma in Ireland continued
Trutz Haase 
We were deeply saddened to learn of the death of Trutz Haase at Easter. Those 
involved with the preparation of the current drugs strategy will be familiar with Trutz’s 
work on the performance measurement framework for Drug and Alcohol Task Forces. 
Trutz and co-author Jonathan Pratschke’s report represents very significant progress 
in the task of developing an effective appraisal system for both national and local 
responses to problem drug use and a more rational, fairer and sustainable approach to 
resource allocation. The framework is a further application of the Pobal HP Deprivation 
Index which has been used extensively to guide Irish health, education and social 
welfare policy over many years. 
Trutz’s work on the index and his contribution to social and economic knowledge in 
Ireland was guided by a deep commitment to using science to build a more decent, 
democratic and equal society. He was always rigorous in the application of his deep 
knowledge but enormously generous, patient and good humoured in sharing his 
insights with others. 
We wish to extend our deepest sympathies to Karena, his wife, and to all his family  
in Ireland and in Germany.
Ms Anna Quigley,  
coordinator with 
Citywide Drugs Crisis 
Campaign, introducing 
the Stop the Stigma 
document at the launch 
of the campaign
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18 • There is a common perception that people who use 
drugs engage in criminal activities. This is, of course,  
the case where the drugs and their use are illegal. 
The vast majority of people who use illegal drugs are 
not involved in any criminal activity, other than their 
purchase and use. The authors also argue that other 
linkages between drugs and crime are a result of 
the prohibition framework. For example, the cost of 
accessing a drug increases when it is made illegal, and 
this has been found to increase levels of criminal activity 
among people who use. 
 
Language and stigma
The media is shown to have a strong influence on how the 
public perceives drugs, the people who use them, and 
related issues. The authors argue that media portrayals are 
overwhelmingly negative and focus on two narratives: the 
first links drugs with crime; the second that drug use will 
inevitably result in ‘devastating’ consequences for the user 
and their immediate environment (p. 26). Both of these, 
coupled with the extensive use of negative language when 
reporting on these issues, create an environment in which 
drugs and the people who use them are heavily stigmatised 
and discriminated against (see Figure 1). Indeed, the authors 
argue that no medical condition is more stigmatised than 
‘addiction’ (p. 27). The language used dehumanises and 
alienates people who use drugs from the rest of society, 
thereby identifying them as ‘others’ for whom society 
does not have a responsibility to help. It reinforces the 
misconception that drug use stems from a problem with 
the individual rather than society as a whole. The impact of 
this is that the health needs of people who use drugs are 
not prioritised by society, resulting in a lack of appropriate 
services. Even where services do exist, people who 
experience stigma are less likely to identify themselves to 
services. They argue for a shift in the language used when 
reporting on drug-related issues (see Figure 2).
Figure 1: Vicious cycle of perceptions of people who use drugs
 
Source: Global Commission on Drug Policy, 2018, p. 281
PREVALENCE AND CURRENT SITUATION 
Challenging 
prejudice and 
changing language
The world drug perception problem: countering prejudices 
about people who use drugs1 challenges common public 
perceptions of addiction, drugs, and the people who use 
them. It highlights the importance of language in creating and 
reducing stigma and discrimination. The report is by the Global 
Commission on Drug Policy (GCDP), which describes itself as 
made up of political leaders and leading thinkers from across 
the political spectrum. It sets out to ‘bring to the international 
level an informed, science-based discussion about humane 
and effective ways to reduce the harm caused by drugs to 
people and societies’.2 Since its inception, the GCDP has 
published a series of reports that are ‘technical and political 
reports to ground evidence-based policy recommendations in 
human rights, health and development’.2 The current report 
was published in January 2018.
Misconceptions
Based on earlier reports by the GCDP,3—7 the authors start 
from the premise that ‘the potential harms of drugs for 
people and communities are exacerbated by repressive 
drug control policies at local, national and international 
levels’ (p. 7). At its core, the current report argues that 
drug policy development and reform should be based on 
evidence and factual discussions, instead of being frequently 
characterised by moral debates based on perceptions rather 
than facts. The main body of the report explores commonly 
held perceptions and fears about drugs and the people who 
use them. It then compares them with the evidence available 
and recommends changes that could be enacted to make 
more effective drug policies. In general, this involves a move 
away from a prohibitionist approach. A detailed summary of 
the report is beyond the scope of this article, but a few of 
the perceptions challenged are outlined below:
• Drugs are often perceived to be ‘unnatural contaminants, 
pushed into a society from the outside or by deviant 
forces’ (p. 7). However, using mind-altering substances is 
an almost universal activity across cultures. What varies 
is the cultural acceptability of specific substances; while 
alcohol use may be an acceptable part of social activity 
in some parts of the world, in others it is demonised and 
prohibited. The authors reiterate the finding that the 
‘legal status of a drug does not systematically relate to its 
potential harm’ (p. 11). They argue that by making a drug 
illegal its potential harms are increased for the user. 
• There is a widely held belief that if a person uses certain 
drugs, they will almost inevitably end up dependent on 
that drug. The authors highlight that while illegal drug 
use is relatively common, only an estimated 11.6% of 
those who use are considered to be problematic users 
or have an addiction: ‘The most common pattern of the 
use of psychoactive substances is episodic and non-
problematic’ (p. 14).
NEGATIVE
PORTRAYAL
(media, politics)
CRIMINALIZATION
OF USE
DRUG
USE IS 
IMMORAL
PEOPLE
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Challenging prejudice continued
Figure 2: Recommended language to use when addressing 
addiction and drug use 
 
USE DON'T USE
Person who uses drugs Drug user
Person with non-
problematic drug use
Recreational, casual, or 
experimental users
Person with drug 
dependence, person with 
problematic drug use, 
person with substance 
use disorder; person who 
uses drugs (when use is not 
problematic)
Addict; drug/substance 
abuser; junkie, dope head, 
pothead, smack head, 
crackhead, etc.; druggie; 
stoner
Substance use disorder; 
problematic drug use
Drug habit
Has a X use disorder Addicted to X
Abstinent; person who has 
stopped using drugs
Clean
Actively uses drugs; positive 
for substance use
Dirty (as in ‘dirty screen’)
Respond, program, address, 
manage
Fight, counter, combat 
drugs and other combatant 
language
Safe consumption facility Fix rooms
Person in recover, person in 
long-term recovery
Former addicts; reformed 
addict
Person who injects drugs Injecting drug user
Opioid substitution therapy Opioid replacement therapy
Source: Global Commission on Drug Policy, 2018, p. 301
Recommendations
The authors make six recommendations structured around 
stakeholders, whom they believe have a strong influence on 
how drug policy is shaped. They argue that changing people’s 
perceptions of drugs and the people who use them will 
reduce stigma and discrimination and will contribute to an 
environment in which drug policy reform is driven by facts 
rather than moral beliefs. 
The recommendations are: 
1  Policymakers must aim to change current perceptions of 
drugs and the people who use them by providing reliable 
and consistent information. Their public policy decisions 
should be evidence based, and they should maintain their 
position even when it is not in line with public opinion 
that is grounded in a moral view rather than facts. 
2  Opinion leaders, such as the media, religious leaders 
and celebrities, must be responsible in shaping public 
opinions and perceptions on drugs. They should promote 
the use of non-stigmatising and non-discriminatory 
language about drugs and their users.
3  Ordinary citizens need to act as advocates by taking 
part in the debate about drug policy reform; sustaining 
activism and advocacy; and keeping governments and 
other public representatives, as well as the media and 
health and social care professionals, accountable.
4  Agents of law enforcement (including the police 
and members of the judiciary) need to stop acts of 
harassment based on negative perceptions of people 
who use drugs. The incarceration of people who need 
medical and social support must be addressed.
5  The medical community and healthcare professionals 
need to be vocal in promoting evidence-based 
prevention, treatment, and harm reduction services 
so that health and safety are prioritised. They need to 
urgently address ‘perception-based stigma’ (p. 37) in 
healthcare settings.
6  The ministerial segment of the 2019 UN Commission on 
Narcotic Drugs provides an opportunity to review the use 
of language in international documents and negotiations. 
This needs to be acted upon.
Lucy Dillon
1 Global Commission on Drug Policy (2018) The world drug 
perception problem: countering prejudices about people  
who use drugs. Geneva: Global Commission on Drug Policy. 
http://www.drugsandalcohol.ie/28434/
2 For more information on the GCDP, visit:  
http://www.globalcommissionondrugs.org/
3 GCDP (2011) War on drugs. Geneva: GCDP.  
http://www.drugsandalcohol.ie/28476/
4 GCDP (2012) The war on drugs and HIV/AIDS: how the 
criminalization of drug use fuels the global pandemic.  
Geneva: GCDP. http://www.drugsandalcohol.ie/28477/ 
5 GCDP (2013) The negative impact of the war on drugs on  
public health: the hidden hepatitis C epidemic. Geneva: GCDP. 
http://www.drugsandalcohol.ie/28474/ 
6 GCDP (2015) The negative impact of drug control on public 
health: the global crisis of avoidable pain. Geneva: GCDP. 
http://www.drugsandalcohol.ie/28475/ 
7 GCDP (2016) Advancing drug policy reform: a new  
approach to decriminalization. Geneva: GCDP.  
http://www.drugsandalcohol.ie/26410/ 
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18 Figure 2 presents the rates of first admission between 
1996 and 2016 of cases with a diagnosis of a drug disorder. 
Although the rate decreased slightly in 2016, there has been 
an overall increase in the rate of first admission with a drug 
disorder since 2011. It should be noted that the report does 
not present data on drug use and psychiatric comorbidity, 
so it is not possible to determine whether or not these 
admissions were appropriate. 
Other notable statistics on admissions for a drug disorder in 
2016 include the following: 
• Just over one-half of cases hospitalised for a drug 
disorder stayed under one week (52.6%), while 99% were 
discharged within three months. It should be noted that 
admissions and discharges represent episodes or events 
and not persons.
• 14% of first-time admissions were involuntary.
• Similar to previous years, the rate of first-time admissions 
was higher for men (12.2 per 100,000) than for women 
(4.9 per 100,000).
Seán Millar
1 Daly A and Craig S (2016) Activities of Irish psychiatric  
units and hospitals 2016. Dublin: Health Research Board.  
http://www.drugsandalcohol.ie/27659/ 
Trends in alcohol and 
drug admissions to 
psychiatric facilities
Activities of Irish psychiatric units and hospitals 2016,1 the 
annual report published by the Mental Health Information 
Systems Unit of the Health Research Board, shows that the 
number of new admissions to inpatient care for alcohol 
disorders has stabilised.
In 2016, some 1,260 cases were admitted to psychiatric 
facilities with an alcohol disorder, of whom 445 were 
treated for the first time. Figure 1 presents the rates of first 
admission between 1996 and 2016 for cases with a diagnosis 
of an alcohol disorder. The admission rate in 2016 was similar 
to the previous year, while trends over time indicate an 
overall decline in first admissions. Just under one-third of 
cases hospitalised for an alcohol disorder in 2016 stayed just 
under one week, while 28% of cases were hospitalised for 
between one and three months, similar to previous years.
In 2016, some 943 cases were admitted to psychiatric 
facilities with a drug disorder. Of these cases, 415 were 
treated for the first time. 
Figure 1: Rates of psychiatric first admission of cases with a diagnosis of an alcohol disorder  
per 100,000 of the population in Ireland, 1996—2016
Source: Daly and Craig, 20161
R
at
e 
p
er
 1
0
0
 0
0
0
 p
op
ul
at
io
n
0
5
10
15
20
25
30
35
40
45
50
0
5
10
15
20
25
30
35
40
45
50
1996
46
1997
41
1998
44
1999
42
2000
41
2001
40
2002
36
2003
31
2004
24
2005
25
2006
20
2007
19
2008
19
2009
16
2010
15
2011
13
2012
11
2013
13
2014
10
2015
9.5
2016
9.7
 
Rates
R
at
e 
p
er
 1
0
0
 0
0
0
 p
op
ul
at
io
n
0
2
4
6
8
10
12
1996
6.7
1997
6.5
1998
7.2
1999
7.9
2000
7.8
2001
8.4
2002
6.3
2003
6.1
2004
6.7
2005
7.9
2006
5.9
2007
6.3
2008
6.8
2009
7.4
2010
9.7
2011
7.7
2012
7.8
2013
8.0
2014
8.9
2015
9.8
2016
9.0
 
Rates
0
2
4
6
8
10
12
Figure 2: Rates of psychiatric first admission of cases with a diagnosis of a drug disorder  
per 100,000 of the population in Ireland, 1996—2016
Source: Daly and Craig, 20161
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Results
The respondents reported feeling reasonably prepared 
to recognise key markers of opioid use disorder but felt 
less prepared for other aspects of opioid use disorder 
management, consultation with a patient about their opioid 
use disorder, assessing addiction severity, formulating a 
treatment plan or managing an opioid overdose. Most had 
taken a history from a patient with an opioid use disorder 
(83%) and one-third had witnessed at least one opioid 
overdose. Nevertheless, only a small proportion (10%) had 
seen naloxone administered, and only three had themselves 
administered naloxone in overdose. In comparison, 35% 
of GPs and 63% of GP trainees in parallel surveys had 
administered naloxone.
Just over one-half (52%) of student respondents saw a 
need for wider naloxone availability. For those students who 
were in opposition to wider availability, concerns included 
potential use of naloxone, lack of evidence for the benefit of 
wider availability, and that it might encourage greater opioid 
use. A similar proportion of respondents (54%) supported 
wider naloxone availability among laypeople. 
Conclusions
The study authors noted that while recognition of opioid 
use disorder was reasonably well reported, management 
competencies were, in general, less positive. Few had 
seen naloxone administered or administered it themselves. 
In addition, despite evidence of the effectiveness of lay 
administration of naloxone in preventing fatal overdose, 46% 
of respondents did not support wider naloxone distribution 
among laypeople. The authors suggest that these results may 
reflect students’ lack of exposure to patients with substance 
use disorder and overdose and to gaps in education in 
undergraduate levels.
Seán Millar
1 Hay G, Jaddoa A, Oyston J, Webster J, Van Hout MC, and Rael 
dos Santos A (2017) Estimating the prevalence of problematic 
opiate use in Ireland using indirect statistical methods. Dublin: 
National Advisory Committee on Drugs and Alcohol.  
http://www.drugsandalcohol.ie/27233/
2 Irish Medical Organisation (IMO) (2015) IMO position  
paper on addiction and dependency. Dublin: IMO.  
https://www.drugsandalcohol.ie/24092/ 
3 European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) (2015) Preventing fatal overdoses: a systematic review 
of the effectiveness of take-home naloxone. EMCDDA Papers. 
Luxembourg: Publications Office of the European Union.  
https://www.drugsandalcohol.ie/23289/ 
4 Merchants Quay Ireland (2016) Merchants Quay Ireland:  
annual review 2015. Dublin: Merchants Quay Ireland.  
http://www.drugsandalcohol.ie/26106/
5 Merchants Quay Ireland (2017) Merchants Quay Ireland:  
annual review 2016. Dublin: Merchants Quay Ireland.  
http://www.drugsandalcohol.ie/27910/
6 Klimas J, Egan M, Tobin H, Coleman N and Bury G (2015) 
Development and process evaluation of an educational 
intervention for overdose prevention and naloxone distribution by 
general practice trainees. BMC Medical Education, 15: 206.
7 Tobin H, Klimas J, Barry T, Egan M, Bury G (2018) Opiate use 
disorders and overdose: medical students’ experiences, 
satisfaction with learning, and attitudes toward community 
naloxone provision. Addictive Behaviors. Early online.  
https://www.drugsandalcohol.ie/28290/
Irish medical 
students’ 
experiences and 
attitudes towards 
community naloxone 
provision
Recent research conducted in 2014 by the National 
Advisory Committee on Drugs and Alcohol suggests that 
there are 18,988 opiate users in the Republic of Ireland 
(rate 6.18 per 1,000 population), indicating that Ireland 
has one of the highest estimated rates of problem opiate 
use across 17 countries in the European Union.1 Opiate use 
disorder is an increasingly common condition in healthcare 
systems in Ireland, with over 200 opiate overdose deaths 
occurring annually.2
Naloxone is an antidote for opioid overdose that reverses 
the depressant effects of opiates such as heroin. Naloxone 
has been shown to reduce mortality among people who use 
opioids and its distribution to trained lay users is effective 
for reducing fatal overdose.3 The Naloxone Demonstration 
Project was initiated in the Republic of Ireland in 2015, 
and in that year 600 individuals were trained in how to use 
naloxone.4 To date, more than 400 drug users have been 
prescribed naloxone5 and there have been five recorded 
‘overdose reversals’ that may have contributed to lives 
being saved. 
Evidence suggests that there is support among general 
practitioners (GPs) in Ireland for wider naloxone availability.6 
Nevertheless, medical students’ exposure to patients with 
substance use disorders is limited and usually only occurs 
during general practice and psychiatry placements. In 
addition, there is a lack of formal substance use education 
at undergraduate level in Ireland, along with information 
regarding effective treatments such as naloxone. A recent 
study examined final-year medical students’ learning 
experiences and attitudes towards opioid use disorder, 
overdose, and community naloxone provision as an 
emerging overdose treatment.
In this research,7 published in the journal Addictive 
Behaviors, an anonymous paper-based survey was 
administered to 243 undergraduate medical students 
undertaking their final professional completion module 
prior to graduation from University College Dublin. The 
results were compared with parallel surveys of GPs and GP 
trainees. A total of 197 medical students completed the 
survey (response rate: 81%), with just under one-half being 
male (45%), most being of Irish nationality (77%), and aged 
less than 25 years (63%).
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behaviours and 
infection among men 
who have sex with 
men in Dublin
Evidence suggests that among men who have sex with 
men (MSM) and who use drugs, there is a preference for 
‘sex drugs’, including alkyl nitrites (‘poppers’), crystal 
methamphetamine (‘crystal meth’), club drugs (including 
ketamine and ecstasy) and new psychoactive substances.1 
Drug use for or during sex (‘chemsex’) among MSM has 
caused concern because of the direct effects of the drugs 
themselves in addition to an increased risk of transmission 
of sexually transmitted infections (STIs).
Recent Irish research aimed to assess the prevalence of 
chemsex, associated behaviours and STIs among attendees 
at Ireland’s only MSM-specific sexual health clinic in Dublin, 
over a six-week period in 2016.2 In this study, published in 
the International Journal of Drugs Policy, a questionnaire 
was used to collect demographic data, information 
on sexuality and sexual practice, self-reported history 
of treatment for STIs, and chemsex use. Key variables 
independently associated with treatment for STIs over 
the previous 12 months were identified using multivariable 
logistic regression. Ninety-four per cent of attendees 
who were asked to take part in the study completed the 
questionnaire.
Among the findings, the study authors highlighted the 
following:
• One in four (27%) reported engaging in chemsex within 
the previous 12 months. 
• One-half had taken two drugs on their last chemsex 
occasion. 
• One in five (23%) reported that they or their partners had 
lost consciousness as a result of chemsex. 
• One in four (25%) reported that chemsex was impacting 
negatively on their lives and almost one-third (31%) 
reported that they would like help or advice about 
chemsex.
It was also found that those engaging in chemsex were more 
likely to have had more sexual partners (p<0.001), more 
partners for anal intercourse (p<0.001) and to have had anal 
intercourse without a condom (p=0.041). They were also 
more likely to report having been treated for gonorrhoea 
over the previous 12 months (adjusted OR: 2.03, 95% CI 
1.19—3.46, p=0.009). Overall, 6% of participants reported 
that they had ever been diagnosed with HIV, though 
no significant difference was seen in the proportion of 
respondents who reported having been diagnosed with HIV 
according to whether they reported that they had (8%) or 
had not (5%) engaged in chemsex (p=0.097).
The authors concluded that the results from this survey 
of MSM clinic attendees in Dublin agree with international 
evidence suggesting a chemsex culture among a subset of 
MSM. They hope that these findings will be used to develop 
an effective response that addresses addiction and sexual 
ill-health among MSM who experience harm, and seek help 
as a consequence of engagement in chemsex.
Seán Millar
1 McCarty-Caplan D, Jantz I and Swartz J (2014) MSM and drug 
use: a latent class analysis of drug use and related sexual risk 
behaviors. AIDS and Behavior, 18(7): 1339—51.
2 Glynn RW, Byrne N, O’Dea S, Shanley A, Codd M, Keenan E,  
et al. (2018) Chemsex, risk behaviours and sexually transmitted 
infections among men who have sex with men in Dublin,  
Ireland. International Journal of Drug Policy, 52: 9—15.  
https://www.drugsandalcohol.ie/28327/
Factors associated 
with alcohol 
involvement in 
suicide and self-
harm in Ireland
Alcohol misuse and alcohol consumption are significant 
risk factors for suicidal behaviour. Persons diagnosed with 
alcohol use disorder have been shown to be at increased 
risk of suicide in a meta-analysis of cohort studies,1 and 
the lifetime risk of suicide among those with alcohol 
use disorder has been estimated at 7%.2 In addition, 
subjects admitted with alcohol use disorder are more 
likely to present with self-harm during a 12-month follow-
up period.3 However, although numerous studies have 
demonstrated an association between alcohol consumption 
and suicidal behaviour, very little attention has been paid to 
the factors associated with alcohol involvement in suicide 
and self-harm. A recent study conducted in Ireland sought 
to identify factors associated with alcohol consumption in 
cases of suicide and non-fatal self-harm presentations.4
In this research, published in the journal Crisis, suicide 
cases in Cork, from September 2008 to June 2012, were 
identified through the Suicide Support and Information 
System. Emergency department presentations of self-harm 
for the years 2007—2013 were obtained from the National 
Self-Harm Registry Ireland. Logistic regression analysis was 
used to estimate independent variable associations with 
alcohol use prior to or during a suicide or self-harm act. 
Key findings included the following:
• Alcohol consumption was detected in the toxicology of 
44% of 307 suicide cases.
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• Only younger age was significantly associated with having 
consumed alcohol among suicides.
• Alcohol consumption was noted in 21% of 8,145 self-harm 
presentations.
• Variables associated with having consumed alcohol in 
a self-harm presentation included male gender, older 
age, overdose as a method, not being admitted to a 
psychiatric ward, and presenting out-of-hours.
The study authors concluded that public health measures 
to restrict access to alcohol may be used to enhance 
suicide prevention, as population-based studies show 
reduced suicide rates following measures to restrict 
access to alcohol.5 In addition, as it was found that alcohol 
involvement was associated with different characteristics 
in self-harm presentations, but not in suicide cases, this 
may require a tailored clinical approach to minimise risk of 
further non-fatal or fatal self-harm.
Seán Millar
1 Wilcox HC, Conner KR and Caine ED (2004) Association 
of alcohol and drug use disorders and completed suicide: 
an empirical review of cohort studies. Drug and Alcohol 
Dependence, 76 (Suppl): S11—S19. 
2 Inskip HM, Harris EC and Barraclough B (1998) Lifetime risk of 
suicide for affective disorder, alcoholism and schizophrenia. 
British Journal of Psychiatry, 172: 35—37. 
3 Singhal A, Ross J, Seminog O, Hawton K and Goldacre MJ (2014) 
Risk of self-harm and suicide in people with specific psychiatric 
and physical disorders: comparisons between disorders using 
English national record linkage. Journal of the Royal Society of 
Medicine, 107(5): 194—204.
4 Larkin C, Griffin E, Corcoran P, McAuliffe C, Perry IJ and Arensman 
E (2017) Alcohol involvement in suicide and self-harm: findings 
from two innovative surveillance systems, Crisis, 38: 413—22. 
https://www.drugsandalcohol.ie/28375/  
5 Värnik A, Kõlves K, Väli M, Tooding L and Wasserman D (2007)  
Do alcohol restrictions reduce suicide mortality?, Addiction, 
102(6): 251—56.
Public consultation 
for a new safe 
injecting facility  
in Dublin
In October 2016, the Union for Improved Services, 
Communication and Education (UISCE) was invited to 
be part of the working group formed to discuss the 
proposed supervised injecting facility (SIF) that is planned 
to open in Dublin in 2018. UISCE provides an independent 
representative voice for people who use drugs and helps 
to ensure the sharing of accurate, up-to-date information. 
In order to identify the most important features of the 
proposed facility to the community of end-users, UISCE 
developed a short survey that included aspects identified 
by the working group as necessary to fully represent the 
opinions, thoughts and concerns of people who use drugs 
in public places.
In the survey, which was completed by 93 subjects 
(66% male), a set of questions focused on the person’s 
experience with regard to the specific drugs that they 
choose to inject, how long they have been injecting, and 
where on the body they normally inject. UISCE also sought 
clarification from each participant about the characteristics 
of the areas where they normally inject, what is important 
about these locations, and how they would like to see a 
SIF administered. Additional questions about safety and 
comfort, before and after using drugs, were also included.
Survey findings
Key findings included the following:
• 76% of respondents considered themselves homeless.
• 90% of the respondents affirmed they were currently 
injecting heroin.
• The average period of time that respondents reported 
injecting was 10 years, with a range of between 3 days 
and 30 years.
• In terms of the parts of the body that people who inject 
drugs use most frequently, the majority of the sample 
affirmed they use mostly the arms (52%), groin (31%) and 
legs (16%). Ten per cent stated that they inject all over 
the body (Figure 1).
• 49% of respondents said they inject between one and 
three times daily, with a majority stating that this was 
early in the morning (79%) and before they go to bed 
(73%) (Figure 2).
• 86% of the sample had injected while on the streets  
and 75% stated that they feel unsafe when they are  
on the streets.
In terms of specific injecting locations, the answers varied: 
despite some respondents stating they would inject 
‘anywhere’ or ‘everywhere’, the majority chose ‘back 
lanes’ or ‘covered areas’ (‘parks’, ‘toilets’, etc.). Almost 
all participants pointed out the importance of privacy, the 
need for good lighting, and highlighted the fact that the 
location served as ‘shelter’. Furthermore, factors such 
as ‘having other people around’ (75%) and ‘being close to 
where they bought the drugs’ (74%) also stood out as having 
great importance when choosing a location. Regarding the 
sense of safety and comfort during and after injecting, over 
one-half of respondents affirmed that they are, or have 
been, comfortable injecting in front of other people, while 
23% stated they would feel uncomfortable having other 
people around. 
Alcohol involvement in suicide 
and self-harm continued
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18 information to inform development. It was identified that 
a city centre location would be ideal. The percentage of 
people who identify as femoral injectors (31%) and the 
people who inject ‘all over their body’ (10%) highlight the 
need for space in the SIF to be designed with these people 
in mind. In addition, there is a need for education on safe 
injecting practices to be made available. In the recovery 
space, as demonstrated by the responses, there will need 
to be coffee and tea facilities as well as a smoking area. 
In addition, as there are high numbers of people who are 
homeless, coupled with high numbers of people who say 
that their preferred action after using drugs is to sleep, 
UISCE recommends support for people to access day 
services from the SIF.
Compiled by Seán Millar
The report on which this article was based was prepared by 
UISCE from the findings of a survey among people who use drugs 
in public places in Dublin. We are grateful to Hannah Rodrigues, 
coordinator with UISCE, who provided this report to us. 
When respondents were asked about location and opening 
hours for a SIF, the answers varied extensively. While some 
people affirmed that they would travel ‘anywhere’ or 
‘everywhere’, the majority said they would like it to be near 
the city centre or even close to a clinic. Regarding opening 
hours, the majority of respondents agreed it should be 
a service available 24/7 with a few exceptions. Finally, 
regarding the ideal set-up of the facility, it was agreed that 
some basic equipment, such as mirrors, tables and chairs, 
was essential. The answers highlighted the need to feel 
comfortable and of having access to medical professionals.
Conclusions
UISCE concluded that there is demonstrable support 
from the community of people who inject drugs in public 
places in Dublin for a SIF, which was indicated by the 
willingness of people to take part in the survey and share 
New safe injecting facility  
in Dublin continued
Source: UISCE, 2018
Figure 1: Preferred injecting locations among UISCE survey respondents
Figure 2: Daily injecting times among UISCE survey respondents
Source: UISCE, 2018
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This is supported by the available evidence which suggests 
that dependence is more common for those who misuse 
pregabalin rather than gabapentin.5,7 
However, it is clear from the literature reviews that 
individuals who misuse pregabalin and gabapentin are taking 
(often much) higher than recommended doses and the 
vast majority have a history of misuse of or dependence 
on other drugs, in particular, opioids.5,7 This is supported 
by studies that show prevalence of gabapentinoid misuse 
among opioid substitution treatment clients varied from 3% 
to 68%.7
The literature states that people who misuse opioids 
appear to use gabapentinoids, in particular pregabalin, to 
achieve a quicker euphoric high and reduce withdrawals.5 
This close association with this high risk population is 
most likely to be influencing the increased prevalence of 
misuse/dependence and serious side-effects, including 
fatal overdose, rather than pregabalin or gabapentin solely 
as primary drugs of misuse or dependence.5 Some studies 
show higher prevalence of misuse among psychiatric 
patients and within prisons.7 It is not clear if this is directly 
related to drug misuse/dependence or a separate concern. 
In Ireland, the National Drug Treatment Centre (NDTC) 
tested 425 opioid substitution clients for pregabalin in 2014 
following requests from health professionals concerned 
about misuse of this drug.8 In all, there were 498 samples 
across seven different clinics: 8.8% of samples tested 
positive, equivalent to 39 of 425 clients (9.2%) testing 
positive. Only 10 (10/39, 25.6%) clients were known to have 
been prescribed pregabalin.
Of those clients who tested positive for pregabalin, the 
average age was 38 years and the majority (59%) were 
female. Also published in 2014 was a case study of an 
individual with a history of drug misuse and dual diagnosis 
of mental illness who misused pregabalin.9 
Risks associated with overdose
A known side-effect of pregabalin and gabapentin is central 
nervous system depression (ranging from sleepiness and 
drowsiness to difficulty breathing, coma and death). The 
literature suggests that potential risks of serious side-
effects are greater for pregabalin than for gabapentin, 
although fatal overdose from either alone is thought to 
be very rare.5,7 However, users prescribed the drugs are 
specifically advised not to take them with other drugs that 
may also negatively affect the central nervous system, such 
as opioids, benzodiazepines or alcohol. This is because they 
may interact together and have an additive effect, which in 
turn may increase the risk and severity of the serious side-
effects, including death.
In Ireland, a recent study (see page 18) found that the 
annual number of intentional drug overdoses involving 
gabapentinoids, mainly pregabalin, increased year on year 
from 0.5% in 2007 to 5.5% in 2015.10 The majority were 
women (59.9%), with a median age of 37 years (74.6% 
were aged 24—54 years). Over one-half (52.4%) involved 
multiple drugs, while over one-third (37.2%) involved 
alcohol. However, history of drug misuse or dependence 
was unknown.
Overview on 
pregabalin and 
gabapentin
In Europe, concerns about the potential risk for misuse 
of or dependence on the prescription drugs pregabalin 
and gabapentin have been raised for at least a decade. 
This article brings together a brief overview of some of 
the main international and national literature to date. In 
2009, pregabalin and its potential involvement in drug-
related deaths in Finland, Sweden and the United Kingdom 
(UK) was reported to the EMCDDA Early Warning System.1 
A retrospective analysis of German data showed that as 
early as 2008 cases of pregabalin misuse/dependence were 
reported in that country.2 However, several years earlier in 
2005, the United States (US) made pregabalin a controlled 
drug due to the recognition of the potential risk of misuse 
and/or dependence.3
What is pregabalin? 
Pregabalin is a prescription-only drug, licensed to treat 
a number of serious conditions: epilepsy (antiseizure), 
neuropathic pain, e.g. caused by shingles (pain relief) 
and also for generalised anxiety disorder (antianxiety). A 
common brand name for pregabalin is Lyrica®. Pregabalin 
and gabapentin are frequently discussed together in the 
literature, usually under their group name ‘gabapentinoid’. 
This is because they are a similar type of drug, both cited 
as having a risk of misuse or dependency. A common brand 
name for gabapentin is Neurontin®. There has been a 23% 
increase in the number of GMS prescriptions for pregabalin 
in Ireland between 2008 and 2016 (unpublished data from 
the Primary Care Reimbursement Service).
What is gabapentin?
Gabapentin is a prescription-only drug, similar to 
pregabalin, and prescribed for epilepsy (anticonvulsant) 
and neuropathic pain (pain relief). Literature referring to 
pregabalin and gabapentin often refer to their ‘off label’ 
use. This means the drugs are being prescribed (or used) 
for a condition outside the terms of its original product 
authorisation (or in different doses or to patient groups 
not specified in the authorisation).4 Over the past decade 
there has been a massive increase in Europe in the number 
of prescriptions for pregabalin and gabapentin.5, 6 Analysis 
of UK data showed that there was a 24% increase in the 
number of gabapentinoid prescriptions between 2004  
and 2015.6
Risk of misuse/dependence
The drugs are reported to give feelings of euphoria and 
relaxation.5,7 Studies have shown that people do experience 
tolerance and subsequent withdrawal symptoms on 
stopping pregabalin and gabapentin; however, this is less 
common for those who use gabapentin. There are very few 
documented cases of dependence (rather than misuse) 
in Europe.5 Pregabalin appears to have a greater potential 
for misuse or dependency because of its more rapid 
absorption and potency.5 
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professionals, June 2003. Dublin: Irish Medicines Board. 
Available online at: https://www.hpra.ie/docs/default-source/
publications-forms/newsletters/drug-safety-newsletter-issue-
no-17-june-2003-(guidance).pdf?Status=Master&sfvrsn=2 
5 Bonnet U and Scherbaum N (2017) How addictive are 
gabapentin and pregabalin? A systematic review. Eur 
Neuropsychopharmacol, 27(12): 1185—215.
6 Lyndon A, Audrey S, Wells C, Burnell ES, Ingle S, Hill R, et al. (2017) 
Risk to heroin users of polydrug use of pregabalin or gabapentin. 
Addiction 112: 1580—589. 
7 Evoy KE, Morrison MD and Saklad SR (2017) Abuse and misuse of 
pregabalin and gabapentin. Drugs, 77(4): 403—26.
8 McNamara S, Stokes S, Kilduff R and Shine A (2015) Pregabalin 
abuse amongst opioid substitution treatment patients. Ir Med J, 
108(10): 309—10. https://www.drugsandalcohol.ie/24965/
9 Osman M and Casey P (2014) Pregabalin abuse for  
enhancing sexual performance: case discussion and  
literature review. Ir J Psychol Med, 31(4): 281—86.  
https://www.drugsandalcohol.ie/22563/ 
10 Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ and  
Arensman E (2018) Intentional drug overdose involving  
pregabalin and gabapentin: findings from the National Self-Harm 
Registry Ireland, 2007—2015. Clin Drug Investig, 38(4): 373—80. 
https://www.drugsandalcohol.ie/28436/
11 Health Research Board (2017) National Drug-Related Deaths 
Index 2004 to 2015 data. Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/28086/
12 Ana Liffey Drug Project (2018) Pregabalin fact sheet. Dublin:  
Ana Liffey Drug Project. Available online at:  
http://www.drugs.ie/pregabalin 
13 Corrigan D (2016) Concern increasing over the emergence of 
pregabalin as a drug of abuse. Irish Pharmacist, 18(3): 20.  
https://www.drugsandalcohol.ie/26786/
14 Public Health England and NHS England (2014) Pregabalin and 
gabapentin: advice for prescribers on the risk of misuse. Available 
online at: https://www.gov.uk/government/publications/
pregabalin-and-gabapentin-advice-for-prescribers-on-the-risk-
of-misuse
15 Wockhardt UK (2017) Package leaflet: information for the user: 
pregabalin. Available online at: https://www.hpra.ie/img/
uploaded/swedocuments/PIL-2192445-31082017145017-
636397878185312500.pdf
16 Advisory Council on the Misuse of Drugs (2016) Letter to 
Minister for preventing abuse and exploitation re pregabalin and 
gabapentin advice. London: Advisory Council on the Misuse of 
Drugs. Available online at: https://www.gov.uk/government/
uploads/system/uploads/attachment_data/file/491854/ACMD_
Advice_-_Pregabalin_and_gabapentin.pdf
17 UK Home Office (2017) Closed consultation: pregabalin and 
gabapentin: proposal to schedule under the Misuse of Drugs 
Regulations 2001. London: Home Office. Available online at: 
https://www.gov.uk/government/consultations/pregabalin-and-
gabapentin-proposal-to-schedule-under-the-misuse-of-drugs-
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Fatal overdose
Fatal overdoses related to gabapentinoids, mostly 
pregabalin, have been reported from the US, Finland, 
Sweden, Germany and the UK in the literature.5,6,7 These 
deaths appear to be almost always in combination with 
other drugs. The numbers of fatal overdoses reported have 
increased over the past decade. Of note, in the US where 
pregabalin has been controlled since 2005, gabapentin is 
more commonly implicated in fatal overdoses.5
The National Drug-Related Deaths Index is a census of 
all drug-related deaths in Ireland. Pregabalin has been 
implicated in fatal overdoses since 2009, although initially 
in small numbers (less than five per year).11 The first 
significant increase was observed in 2013, with 14 deaths 
recorded where pregabalin was implicated. However, 
between 2014 and 2015, the number of deaths where 
pregabalin was implicated had increased by 69%, from 26 
to 44. Of note, pregabalin has only been routinely screened 
for in postmortem toxicology in Ireland since 2013. 
Summary
The evidence from Ireland, however limited, does 
mirror the available international literature on the risks 
of pregabalin and gabapentin. A factsheet12 has been 
produced and there has been a call to consider making 
pregabalin a controlled drug.13
In 2014, the UK government issued advice for prescribers 
on the potential risk of misuse of both pregabalin and 
gabapentin.14 It advises caution in particular when 
considering prescribing a gabapentinoid to a person  
with a known history of drug misuse or dependence. 
However, this should not preclude them prescribing the 
medication if the benefit outweighs the risk. In Ireland, 
the patient factsheet on pregabalin, under warnings and 
precautions, urges patients to inform their doctor if they 
have a history of alcohol or drug dependence, or misuse 
of drugs before starting the medication.15 In 2017, the 
UK government commenced the process to make both 
pregabalin and gabapentin controlled drugs in response  
to concerns raised.16, 17 
Suzi Lyons
1 European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) (2010) Annual report 2010: the state of the drugs 
problem in Europe: new drugs and emerging trends.  
https://www.drugsandalcohol.ie/14182/
2 Gahr M, Freudenmann RW, Hiemke C, Kölle MA and Schönfeldt-
Lecuona C (2013) Pregabalin abuse and dependence in Germany: 
results from a database query. Eur J Clin Pharmacol, 69(6): 
1335—42.
3 Federal Register (2005), Vol. 70, No. 144 / Thursday, July 28, 2005 
/ Rules and Regulations 43633. Washington DC: Office of the 
Federal Register. Available online at: https://www.gpo.gov/fdsys/
pkg/FR-2005-07-28/pdf/05-15036.pdf
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The report looks at the findings of a 2015 study that sought 
to gain a better understanding of the extent of darknet drugs 
sales originating from Europe.3 Based on data gained from 
buyer feedback reports, the study estimated the volumes 
and value of drugs traded over a period of about three and 
a half years. The data suggest that the vast majority of sales 
originating from the EU during this period were from three 
countries: Germany (€26.6 of sales); the United Kingdom 
(UK) (€20.2m of sales); and the Netherlands (€17.9m of sales) 
(see Figure 1). The most common substances sold in the 
top four countries (including Belgium) were non-cocaine 
stimulants, principally MDMA and amphetamines. Cannabis 
and cocaine sales were also significant in the sales from these 
countries, while the UK-based sites were far more likely to 
sell dissociatives and new psychoactive substances. In terms 
of drug sales, EU countries represent roughly 46% of global 
revenue. A more detailed 2017 study of AlphaBay,2 one of the 
most important darknet marketplaces and active for about two 
years, shows that the vast majority of drugs sales originated 
from the same three countries identified in the 2015 study. 
Drugs and the 
darknet: new 
EMCDDA report
Two-thirds of sales on darknet markets are drug related. These 
anonymous online markets enable transactions with neither 
buyer nor seller having to reveal anything about their identify. 
So-called ‘cryptomarkets’ are a relatively new phenomenon 
but the opportunity they present to undermine conventional 
law-enforcement approaches inevitably means that they will 
be a driver of significant growth in criminal activities over 
the next few years. A recent EMCDDA publication, Drugs 
and the darknet: perspectives for enforcement, research 
and policy1 presents an analysis of drug-related activity on 
darknet markets, focusing on specific European countries and 
also looking at the phenomenon from the perspective of law 
enforcement agencies required to monitor and counter the 
operation of these markets.
In 2017, Europol identified the online trade in illicit goods 
and services as a key growth area for organised crime.2 
Darknet markets are websites that allow anonymous financial 
transactions. Access to these markets can be through 
ordinary, surface websites providing addresses for darknet 
sites; through surface mirror sites with links to hidden sites; 
or through invitation following reference from an existing 
user. The key technologies supporting these markets are 
anonymisation services, encrypted communication and 
cryptocurrencies, such as Bitcoin or Dogecoin. Users 
seeking to make illicit sales can use a search engine, Grams, 
specially designed for this purpose. Innovative use of instant 
messaging for communication and social media applications 
with GPS (global positioning systems) technologies presents 
particular difficulties for surveillance and regulatory work. 
In addition, many darknet markets offer their customers 
an escrow service with a multisignature function and the 
guarantee that the goods paid for will be delivered.
The first of these cryptomarkets was Silk Road, closed down 
by American law enforcement agents in 2013. Since then, an 
estimated 100 darknet markets have been created, many of 
which only operate for a short time (see Figure 2 overleaf). 
At the time of the EMCDDA report being written, there 
were an estimated 14 darknet markets operating. Despite 
the methodological and practical difficulties of researching 
darknet markets, a number of studies have provided useful 
data and at least highlight areas that will need further 
investigation and monitoring. Much of this work has focused 
on the behaviour and experience of those purchasing drugs 
online. Demographic characteristics were consistent across a 
number of studies with young, student or professional males 
with a history of drug use being the most common type of 
users in the limited samples observed. Personal safety and 
drug quality were the most frequently cited considerations 
when choosing to use online sources for drugs. While 
the purity of drugs purchased online does vary, a limited 
number of studies do show that what is ordered online will 
subsequently be delivered, and that those who purchase 
online usually find the suppliers are reliable. Websites use 
facilities such as marketplace feedback and rating polls to 
build confidence in their reliability and the quality of the 
products they supply. Researchers have used feedback data as 
a source of information in studying darknet activity.
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Figure 1: Breakdown of sales revenues originating from the EU, 
Norway and Turkey by country, 2011—2015
(a) Breakdown by revenue (major countries)
Source: EMCDDA, 2017, p. 33
(1)  Multiple denotes where several EU countries are mentioned as country of 
origin. Note: For readability, the three major countries (Germany, the United 
Kingdom and the Netherlands) are represented on a different scale.
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(b) Breakdown by revenue (other countries)
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18 and the development of responses that are technologically 
informed, coordinated and collaborative. Implementation of 
this response will require increased investment to support 
specialist investigation capacities. There needs to be 
pooling of resources at the European level to coordinate 
activities across jurisdictions, especially in light of recent 
judicial decisions. A framework for improving criminal 
justice in cyberspace is set out in the recent European 
Council conclusions.4
There are significant knowledge gaps around the darknet 
trade in drugs, especially regarding the actors and 
mechanisms not apparent through observation of online 
transactions. Currently, very little is known about the 
sources of drugs supplied on darknet markets or how the 
supply chain is organised (see Figure 3). It is also important 
to get a better understanding of what makes buying 
and selling online attractive and why online behaviour 
changes according to region. Potential further threats 
include development of decentralised software and new 
encryption technologies; changes in parcel delivery services; 
integration of local markets with online markets; and 
greater concentration on national online markets to avoid 
customs detection. Future software developments may allow 
websites to be hosted across several servers, countering 
current responses that involve targeting specific servers. 
This development, combined with innovative use of social 
media, instant messaging and GPS, may enable a highly 
efficient drug distribution network linked to local markets 
undermining existing markets and posing greater challenges 
to law enforcement. As yet, this remains a potential threat, 
but it underlines the importance of systematic monitoring of 
anonymous online activity. 
Brian Galvin
1 European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) and Europol (2017) Drugs and the darknet: 
perspectives for enforcement, research and policy. 
Luxembourg: Publications Office of the European Union.  
https://www.drugsandalcohol.ie/28246 
2 Europol (2017) European Union Serious and Organised Crime 
Threat Assessment (SOCTA): crime in the age of technology.  
The Hague: Europol. Available at: https://www.europol.europa.
eu/activities-services/main-reports/european-union-serious-
and-organised-crime-threat-assessment-2017 
3 Soska K and Christin N (2015) Measuring the longitudinal evolution 
of the online anonymous marketplace ecosystem. In Proceedings 
of the 24th USENIX Security Symposium, Washington DC, 12—14 
August 2015, pp. 33—48. Available online at: https://www.usenix.
org/system/files/conference/usenixsecurity15/sec15-paper-
soska-updated.pdf 
4. Council of the European Union (2016), Council conclusions on 
improving criminal justice in cyberspace of 9 June 2016, doc. 
10007/16. Available online at: https://www.consilium.europa.eu/
media/24300/cyberspace-en.pdf 
Analysis of sales data shows that vendors tend to confine 
their activity to one market level: retail, middle or wholesale. 
In other words, very few vendors are involved in both bulk 
and small volume sales. While the majority of these vendors 
operate at the lower market level, it is estimated that just 
1% of vendors are responsible for more than 50% of darknet 
sales. These sellers are connected to organised crime 
gangs and make considerable profits. Law enforcement 
authorities expect online markets to take an increasing 
share of the overall illicit drug market and may even replace 
the use of traditional distribution networks among some 
user demographics. The EMCDDA report describes darknet 
markets as ‘tailor-made polycriminal environments’, as they 
allow criminal groups to distribute a wide range of illicit 
commodities, with no restriction on the type of drugs they 
trade in online. The increasing professionalism of darknet 
markets suggests to law enforcement observers that 
criminals involved in distributing drugs via street dealers are 
increasingly using darknet market trading as an additional 
distribution channel and revenue stream. Law enforcement 
actions such as taking down major marketplaces have only a 
short-term effect, as both vendors and customers will move 
to alternative sites or new darknet markets will emerge.
In 2014, the European Court of Justice ruled that retention 
of data by internet service providers for law enforcement 
purposes was no longer legal, a ruling that has been 
interpreted and implemented differently in EU member 
states. Though its ultimate impact is uncertain, the ruling 
has reduced the ability to effectively prosecute online 
criminal activity. While international legislative instruments 
do exist, differences with domestic law often impede 
criminal investigations with an international dimension. 
An additional difficulty is the sometimes cumbersome 
nature of international cooperation, which often slows 
the investigative process, an important consideration in 
gathering electronic evidence. While a sustainable response 
to illegal online markets will require a significant increase 
in cybercrime expertise, a number of more traditional 
responses have been reasonably effective, including 
monitoring of postal and parcel deliveries.
Drug sales account for around two-thirds of all 
cryptomarket transactions reviewed. Effective responses 
to cybercrime require the same technological ability and 
innovative thinking as that displayed in criminal practice. 
This study provides the conceptual framework necessary 
to understand developments in this area. It includes an 
EU-focused analysis of darknet operations and of the 
challenges faced by law enforcement in responding to 
it. Market disruption needs to form part of an integrated 
set of measures, including identifying and targeting major 
vendors, dealing with key elements in the supply chain, 
Drugs and the darknet continued
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are mainly small convenience samples that treat older 
adults as a homogenous group and/or compares them to 
their younger counterparts. 
• Research lacks large quantitative studies explicitly 
examining the area, and existing treatment monitoring 
systems are not being utilised. 
• Although opioid treatment numbers are decreasing, the 
average age of treatment admissions is increasing. 
• Current literature points to the existence of two distinct 
types of older opioid substance users (early and late-
onset subgroups), which have yet to be studied in depth. 
• Although limited, there is some evidence that older 
treatment clients achieve better treatment outcomes 
than younger counterparts, and older women achieve 
better treatment outcomes than men.
• The ageing opioid-using population will present many 
challenges for policymakers and healthcare providers 
who are typically accustomed to working with younger 
drug users. 
The authors note that important issues related to the 
care of older people with substance use problems 
(medical, psychiatric, multimorbidity, cognitive decline, 
social isolation, mediation drug interactions, burden of 
medications, etc.) have been excluded due to the narrow 
focus of the review. However, they note that outcome 
measures such as employment and involvement in criminality 
may be less appropriate for the older population, particularly 
in the case of the late-onset group who are at a later stage 
of life and financial security.
The article highlights that much work is required to 
effectively prepare for and respond to the needs of older 
people, including developing effective prevention and 
treatment responses (service availability, treatment models, 
workforce awareness and training), developing tools to 
measure substance use and abuse among older adults, and 
providing adequate data to measure emerging problems and 
predict future trends.
The study concludes that ageing populations who use opioids 
are a neglected topic within the literature, and highlights the 
importance of understanding their specific needs in order 
to prepare for and deliver appropriate care. Problematic 
drug use (of which opioids make up the largest proportion) 
had been incorrectly assumed to end as people age. The 
authors recommend further research using large samples to 
investigate subgroups in more detail. 
Anne Marie Carew
1 Carew AM and Comiskey C (2018) Treatment for opioid  
use and outcomes in older adults: a systematic literature  
review. Drug Alcohol Depend, 182(Suppl C): 48—57.  
http://www.drugsandalcohol.ie/28129/ 
Treatment for opioid 
use and outcomes in 
older adults
A recent systematic review examining treatment for opioid 
use and outcomes among older adults was published in the 
journal, Drug and Alcohol Dependence.1 The review aim was 
first to identify and distil key literature on ageing among people 
treated for opioid use, and secondly to investigate immediate 
treatment outcomes such as retention and abstinence. 
The review consisted of targeted databases searches, 
supplemented by manual grey literature searches. Only 
articles explicitly involving individuals who received addiction 
treatment for opioid use were included in the study. The 
review was conducted in accordance with Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines, and 76 papers were included in the review 
synthesis. The study lists a number of factors why large 
numbers of opioid users are living longer. These include:
(1) Demographic changes and increased life expectancy in 
the general population, (2) ageing baby-boom and post-
baby-boom cohorts (50 years-and-older age group) who 
experienced increasing levels of drug availability over time 
along with higher rates of illicit drug use during their youth, 
(3) developments in and improved access to healthcare, 
harm reduction and drug treatment services leading to 
increased longevity among drug users.
The authors found:
• The numbers of older drug users have been increasing 
internationally for the last 40 years, yet there is a dearth 
of literature addressing problematic drug use among 
older people. 
• Evidence from epidemiological surveys and treatment 
admissions within developed countries show that people 
with opioid-use problems are ageing. This trend is 
likely to grow for the next two decades and place new 
demands on drug treatment services. 
• There is no consensus in the literature on the definition 
of ‘old’, which ranges from 37—55, 40+, 45+, 50+, 60+, 
65+, 49—61, 50—59, and 50—74 years of age. 
• Issues relating to problem opioid use among older people 
have only recently been recognised and the literature 
calls for more attention to be given to this topic. 
• Little is known about the characteristics of ageing among 
the opioid treatment population and there has been little 
discussion of appropriate treatment services for this 
group. 
• Existing research on older adults is predominately 
from the United States and mainly involves alcohol and 
prescription medications, while existing larger-scale 
longitudinal studies tracking treatment and health 
outcomes have failed to include a significant sample of 
older people. 
• Only a handful of studies have examined opioid treatment 
admissions among older adults. However, these studies 
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18 to attempt an IDO and are more likely to take an antiepileptic 
(one indication for gabapentinoids) and are more likely to 
be prescribed an antiepileptic. This may explain why there 
were more women than men treated for IDOs involving 
gabapentinoids. 
The authors note with concern the involvement of alcohol, 
even though it was slightly lower for IDOs involving 
gabapentinoids compared with other drug groups. Evidence 
shows that involvement of alcohol in an IDO is associated 
with repeat attempts, impacts on patient treatment and 
hospital resources. Mixing prescription drugs with alcohol 
also increases the risk of fatal overdose, particularly as both 
the gabapentinoids and alcohol are central nervous system 
depressants. The study also showed that this group was 
more likely to be admitted to hospital, again mirroring other 
research that shows that IDOs involving antiepileptics require 
more intensive medical and psychiatric treatment. 
The large number of tablets consumed by this particular 
group is also worth mentioning. Often cases of larger 
numbers of tablets taken are associated with higher  
suicidal intent. However, choice of drug in IDO is mostly 
determined by availability, so it may be more reflective  
of prescribing trends. 
A number of limitations were highlighted by the authors.  
The study does not have information on intent, whether 
it was suicide or misuse. Another limitation is that the 
numbers of tablets taken were self-reported; however, 
where possible, the National Self-Harm Registry tries to 
corroborate information with other sources. It also does not 
report if any of the study group had a history of misuse of 
other drugs.
The authors state that this study shows the importance of 
responsible and vigilant prescribing for all psychotropic 
drugs, including gabapentinoids, in particular for those with 
a history of previous IDO and/or a history of drug misuse or 
dependence.
Suzi Lyons
1 Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ and Arensman 
E (2018) Intentional drug overdose involving pregabalin and 
gabapentin: findings from the National Self-Harm Registry 
Ireland, 2007—2015. Clin Drug Investig, 38(4): 373—80.  
https://www.drugsandalcohol.ie/28436/
Intentional drug 
overdose involving 
pregabalin and 
gabapentin
This study looked at intentional drug overdoses (IDOs) 
involving pregabalin and gabapentin that were treated in 
emergency departments (ED) in Ireland, from 2007 to 2015, 
as recorded by the National Self-Harm Registry Ireland.1 For 
more in-depth information on pregabalin and gabapentin 
(gabapentinoids), see the overview on page 11. 
Results
The annual number of IDOs involving gabapentinoids 
increased year on year from 0.5% in 2007 to 5.5% in 2015. 
In 2015, there were 369 IDOs involving gabapentinoids, 
the highest number recorded in the study period. In total, 
there were 72,391 IDOs between 1 January 2007 and 31 
December 2015. Of these, 2,115 (2.9%) were known to involve 
a gabapentinoid. Pregabalin was involved in 1,953 cases (2.7% 
of total IDOs; 92.3% of total known gabapentinoid IDO). 
Of those IDOs involving gabapentinoids, the majority were 
women (59.9%), with a median age of 37 years (74.6% were 
aged 24—54 years). Over one-half (52.4%) involved multiple 
drugs, while over one-third (37.2%) involved alcohol. 
Compared to those IDOs that did not involve gabapentinoids, 
the study group was older (median age 37 compared to 
32 years); took significantly larger number of tablets (30 
compared to 21); had less alcohol involvement (37.2% vs 
42.8%); and were more likely to be admitted to hospital 
(general or psychiatric) (39.1% vs 34.0%).
Discussion
This large study showed the significant increase over 
a 10-year period in IDOs presenting to EDs involving 
gabapentinoids, typically involving more women and those in 
early/middle age. This increasing trend in the number of IDOs 
involving gabapentinoids reflects the international evidence. 
International evidence also shows that women are more likely 
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Results
As illustrated by the CSO data, possession of drugs for 
personal use and sale or supply reached a peak in 2008 and 
mainly declined thereafter (Figure 1). A similar trend was 
shown in Figure 2, where controlled drug offences peaked in 
2008 and declined thereafter.
Figure 3 shows that trends for importation drug offences 
were similar to trends shown in Figures 1 and 2. However, 
trends for cultivation or manufacture initially showed a 
steady increase before the recession (2004—2008). But, 
during the recession it thrived; a ‘dramatic increase’ was 
shown between 2009 and 2011. Although a decline was 
evident thereafter, the number of incidents remained higher 
than levels shown before 2009.
In an attempt to explain the Irish drug market trends, Windle 
put forward two hypotheses.
Hypothesis 1: emigration
Windle argued that the trends evident in Ireland contrast 
with the international literature, which has suggested that 
during a recession drug consumption and drug dealing should 
increase. As this was not the case in Ireland, he proposed 
that emigration might be a more apt explanation for the  
Irish findings. 
Impact of the great 
recession on the 
Irish drug market
The dearth of literature examining the relationship between 
economic recessions and drug markets has indicated 
that economic recessions mainly result in higher drug 
consumption and drug dealing. A recent study carried out 
by James Windle at University College Cork examined this 
relationship from an Irish perspective.1 Although the trends 
presented here have already been presented in the Irish 
national report on drug markets and crime (2016),2 Windle 
extended the findings by putting forward explanations as to 
why these trends have occurred. 
Methodology
Controlled drug offence data (2004—2015), recorded by An 
Garda Síochána (AGS) on their police using leading systems 
effectively (PULSE) system and published in annual reports by 
the Central Statistics Office (CSO), were analysed. This data 
acted as a proxy for consumption and drug dealing.
Figure 1: CSO: Number of recorded possession offences (2004—2014) 
Source: Windle, 2017, Figure 2, p. 4 
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Figure 2: CSO: Number of total drug offences (2004—2014) 
Source: Windle, 2017, Figure 3, p. 4
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18 These include, for example, import substitution (i.e. growing 
the product closer to the consumer), being more cost 
effective, allowing control over quality and taste, and having 
no contract with criminals.
Limitations and future research
Throughout this paper, the author and others have 
acknowledged the extensive limitations of the data recorded 
by AGS.3,4 That being said, it is recognised in academic 
research that there are advantages to using official data as it 
not only allows for trends over time to be examined but also 
acts as a primary source of information related to criminal 
activity in Ireland. The author made a number of suggestions 
for further research. For example, triangulating existing 
data with other types of quantitative and/or qualitative 
data; accounting for Irish citizens who emigrated during the 
recession and comparing them with those that stayed; and 
whether austerity measures, such as reduced Garda visibility, 
resulted in a reduction in recorded controlled drug offences. 
Finally, as the outcomes of the recession may not be fully 
known for 10 to 20 years, Windle identified the need for 
longitudinal research to follow children born in the recession 
until adulthood.
Drawing on Irish data from the CSO, he stated that between 
2006 and 2013, emigration increased from 36,000 to 89,000; 
a large number of these individuals were unemployed young 
people. This cohort is known to have higher levels of drug 
consumption.
Hypothesis 2: adaptation
The second hypothesis put forward focused on cannabis 
and postulated that Irish dealers and consumers adapted 
to having a reduced income by growing their own product, 
which contributed to a decline in the importation of drugs. 
Evidence to support this argument can be seen in Figure 
4, where a major increase in cannabis plant seizures was 
evident between 2010 and 2012. Windle argued that the 
steady increase in cultivation illustrated before and during 
the recession could be construed as evidence that the 
recession resulted in adaption. However, he also noted 
that there is a number of other explanations for increased 
cannabis cultivation, which are not related to the recession. 
Source: Windle, 2017, Figure 6, p. 10
Figure 3: CSO: Number of cultivation or manufacture of drugs and importation of drugs offences (2004—2014)
Figure 4: EMCDDA (2016): Cannabis plant seizures (number of plants) (2004—2013)
Source: Windle, 2017, Figure 4, p. 5
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Ciara H Guiney
1 Windle J (2017) The impact of the great recession on the Irish 
drug market. Criminology and Criminal Justice, Nov 10: 1—20. 
https://doi.org/10.1177/1748895817741518 
2 Health Research Board (2017) Focal Point Ireland: national 
report for 2016 — drug markets and crime. Dublin: Health 
Research Board. http://www.drugsandalcohol.ie/25286/ 
3 Central Statistics Office (2016) Review of the quality of  
crime statistics 2016. Cork: Central Statistics Office.  
http://www.drugsandalcohol.ie/26176/
4 Central Statistics Office (2015) Review of the quality  
of crime statistics. Dublin: Government of Ireland.  
http://www.drugsandalcohol.ie/24887/ 
Conclusion
Windle concluded that changes in the drug market 
witnessed in Ireland may be due to young people leaving 
Ireland to seek work, which resulted in a reduction of 
potential consumers. Those that remained availed of 
advances in technology and communications to produce 
their own cannabis, which would have impacted further on 
the quantity of cannabis being imported into Ireland. The 
change evident in Ireland was consistent with those seen 
in other industrialised nations; however, the outcome was 
probably exacerbated by the recession. Windle argued that 
these changes illustrate Ireland’s global interconnectedness 
and emphasised the importance of recognising and 
understanding the influence of global and regional drug 
market trends on the local environment. 
Recession and the Irish  
drug market continued
Beyond Greentown: 
children’s 
involvement in 
criminal networks 
On 13 February 2017, Dr Sean Redmond, adjunct professor of 
youth justice at the School of Law in University of Limerick, 
launched the Lifting the lid on Greentown report, which 
examined the effect of a criminal network on the offending 
behaviour of children between 2010 and 2011 in a regional 
Garda sub-district outside Dublin referred to as Greentown.1,2
Purpose and method
Work in this area is ongoing; a second study aimed to 
determine whether the results of the original study could 
be extended beyond Greentown.3 Similar to the first study, 
three research questions were addressed:
1  Is there evidence of children sharing the same general 
profile found in the original Greentown study in localities 
across Ireland?
2  Is there evidence of children’s involvement in criminal 
networks found in the original Greentown study in 
localities across Ireland?
3  If so, is there evidence of hierarchical difference in 
such networks that are determined by membership of 
dominant families?
Survey respondents
Garda juvenile liaison officers (JLOs) who were involved with 
the Garda Diversion Programme (GDP) across Ireland were 
invited to respond to a survey exploring their knowledge 
of the involvement of children in criminal behaviours. The 
response rate was high (90%) and indicated that all local 
Garda sub-districts were represented in this survey.
Findings
Responses from JLOs suggested that the profile and 
experiences that children had in other criminal areas across 
Ireland were in the main similar to those found in Greentown. 
For example:
• 86% of JLOs reported that children, in particular males 
(94%) aged 16 to 17 years (71%), took part in serious and 
persistent crime. 
• JLOs believed that one in eight children involved in the 
GDP in rural and urban areas fit the same profile as those 
found in Greentown. 
• Risk factors included a range of vulnerabilities; for 
example, being out late at night unsupervised, taking 
alcohol (97%) and taking drugs (88%). Welfare issues were 
also evident, for example, 77% of children were involved 
in welfare investigations. 
• This lifestyle was deemed to appeal to young people as 
it provided access to drugs/alcohol (91%) and money 
(95%), on one level, and respect (89%), power (87%) and 
a sense of belonging (81%) on another. 
Consistent with the Greentown study, evidence based on 
three indicators suggested that some children participated 
in criminal networks in these areas:
• Children referred to JLOs mainly lived in poorer areas 
(80%) with excessive antisocial behaviour (79%). 
Neighbourhoods were dominated by fear, intimidation 
and coercion. For example, residents were afraid of 
negative repercussions (80%) and believed those involved 
in crime would follow through on violent threats (84%). 
In consequence, crimes were not reported (72%) and 
no one would act as a witness (73%) to bring offenders 
to justice. A number of these children participated in 
criminal networks.
• Children participating in criminal networks learned 
practical skills, such as committing crime (86%), 
manipulating the justice system (91%) and manipulating 
authority (86%), from adults who had the most influence 
over them. Notably, these children were not likely to be 
loved or appreciated (43%).
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18 criminal behaviour in their children (80%) than parents of 
associates, 37%, 17%, and 42%, respectively. However, in 
contrast to the Greentown study, parents of family members 
were more likely to have problems with alcohol and drugs 
(77%) and be argumentative with authority figures (95%).
JLOs identified how adults influenced family members and 
associates into criminality:
• Family members were influenced by adults who were 
male (87.5%), a family member (76%), and aged over 36 
years (55%).
• The influence of this adult, more often a father, was 
higher if children were family members (89%). He 
instilled a sense of pride in the family’s reputation (86%), 
threatened violence (81%) and threatened aggression as a 
form of discipline (75%).
• However, associates were more likely groomed by adults, 
who were younger non-family members (‘recruiters’, p. 
2) and by building a trusting relationship (79%). 
Limitations
As acknowledged by the authors, a number of limitations 
was evident. Although the JLO response rate was high, the 
survey relied heavily on the perceptions of one profession. 
Hence, the results reported here may have been susceptible 
to respondent subjective bias. It utilised a cross-sectional 
design that only provided one ‘snapshot’ of what was 
happening at a specific point in time (p. 13). The authors 
highlighted the need to carry out longitudinal research 
and to avail of other sources for data collection, including 
other professionals, children and families involved. Further 
research also needs to examine hierarchical differences 
between those children categorised as family members and 
associates, as evidence in this study was contradictory. 
Conclusion
In the main, the findings of this study have suggested that 
the JLO profile of children involved in serious and persistent 
crime was similar to the profile of children established in 
the Greentown study. Moreover, it is believed that these 
children were also involved with criminal networks. Evidence 
regarding the existence of hierarchies within networks 
outside Greentown was inconsistent. 
Work by this research group continues. The Greentown 
study has been replicated in two other locations and they 
are in the process of analysing data collected from an expert 
panel group to inform the development of an intervention to 
reduce child engagement with criminal networks.
Ciara H Guiney
1 Department of Children and Youth Affairs (2016) Lifting the 
lid on Greentown: why we should be concerned about the 
influence criminal networks have on children’s offending 
behaviour in Ireland. Dublin: Government Publications.  
http://www.drugsandalcohol.ie/26850/ 
2  Guiney C (2017) Lifting the lid on Greentown. Drugnet Ireland, 61: 
13—14. http://www.drugsandalcohol.ie/27205/ 
3 Naughton C and Redmond S (2017) National prevalence 
study: do the findings from the Greentown study of children’s 
involvement in criminal networks (2015) extend beyond 
Greentown? Interim report. Limerick: School of Law, University 
of Limerick. http://www.drugsandalcohol.ie/28326/ 
• JLOs emphasised the challenges for children to 
disengage from crime. This was influenced by the level  
of trust (71%) and bond (71%) between the adult and  
the child. Moreover, having friends that were mainly 
involved in crime was viewed as a major barrier to 
disengagement (72%). Making children accountable for 
their criminal actions (65%), the desire to disengage 
(54%), and having an effective path away from crime 
(60%) were thought to be factors that would deter 
offending behaviour in children. 
The Greentown study indicated that the criminal network 
revolved around one dominant criminal family. Children 
related to the family, referred to as family members, 
thereafter benefited from having a higher status than 
children that were not related, referred to thereafter as 
associates. In addition, family members were ‘relatively 
sheltered’ and did not have the same welfare issues. In this 
study, some of the findings of this part of the analysis were in 
contrast to the findings of the Greentown study. In the main, 
JLOs reported that family members were at higher risk and 
received less protection than associates. For example:
• The majority of family members participated in criminal 
activity before the age of 12 (92%), which was more than 
twice the proportion reported by associates (42%).
• In general, children involved with serious and persistent 
crime were viewed as vulnerable and as having complex 
needs. However, the results showed that family members 
were unlikely to experience protective factors. 
As illustrated in Table 1, JLOs believed that associates were 
more likely to experience higher protective factors than 
family members.
Table 1: Comparison of protective factors experienced by 
children described as family members and associates
Protective factor Family member Associate
Positively influential father 13% 28%
Embedded within a positive 
network
20% 47%
Participated in community 
groups, such as sports or art
8% 30%
Source: Naughton and Redmond, 2017, p. 10
Despite these findings, there was also evidence in support 
of the findings of the original study. Consistent with the 
Greentown study, for example, the majority of family 
members became involved in crime in order to live up to 
the family reputation (97%), to feel protected (77%), and 
because they believed that they had no choice (54%). Family 
members were also 50% less likely than associates to move 
to a new location to disengage from the network, from family 
members (34%) and from associates (60%).
Moreover, similarities were evident regarding the home life 
experienced by children. Parents of family members were 
more likely to be involved in crime (92%), convicted within 
the last six months, and were more likely to encourage 
Children’s involvement in  
criminal networks continued
23
Issue 65 | Spring 20
18
     drugnet IR
ELAN
D
      
Objecting to a proposed grant or renewal  
of a licence
How can I know that an application is being made?
Applicants for a new licence must advertise their intention 
to make such an application in a newspaper circulating 
in the place in which the proposed premises are situated 
at least 21 days before the application is to be made. The 
superintendent of the Garda Síochána of the district in 
which the premises are situated also must be put on notice 
of any application for a new licence. An applicant intending 
to apply for an annual public dancing licence must publish 
notice of their intention to do this at least one month before 
the hearing. Existing licences must be renewed each year by 
Revenue. Most licences expire on 30 September each year, 
with the exception of wholesale dealer’s licences that are 
held in conjunction with other off-licences; in these cases, 
licences expire on 30 June. 
What licences can be objected to?
Members of the public can object to any application for a 
new licence or any renewal of a licence in the civil parish in 
which they live or otherwise occupy or pay rates (e.g. as a 
business person). In relation to public dancing licences, any 
person who appears, to the judge, to be interested in the 
application may be heard in opposition. The superintendent 
of the Garda Síochána of the district in which the premises 
are situated is also a competent objector. 
Where and when can I object?
Applications for new on-licences are made to the Circuit 
Court in the town nearest the premises and in the county 
in which the premises are situated. An objection in writing 
(which is not necessary) should be addressed to the county 
registrar of that circuit. Applications for new off-licences are 
made to the District Court in which the premises is situated. 
Objections in writing (which is not necessary) should be 
addressed to the District Court clerk for that district. 
Objections to renewals should be made to the relevant 
District Court for the premises. The very first application for 
a public dancing licence may be made at any sitting of the 
District Court in which the premises is situated. Subsequent 
applications must be made in September each year at the 
annual licensing court.
The main grounds of objection
The main grounds of objection are as follows:
• The character, misconduct or unfitness of the applicant: 
Character and misconduct are generally considered 
together and relate to an applicant’s public reputation; 
unfitness refers to the applicant’s fitness to run a 
licensed premises.
• Unfitness or inconvenience of the new premises: A 
premises will not be fit and convenient if it has previously 
been disqualified from ever being licensed; or a license in 
respect of the premises has previously been forfeited.
• Unsuitability for the needs of persons residing in the 
neighbourhood: To advance an objection on this ground, 
an objector would need to be clear on who are the 
persons that reside in the neighbourhood; what are their 
needs; and how the proposed new premises is unsuitable 
for those needs.
POLICY AND LEGISLATION 
Alcohol licensing  
in Ireland
Because of concerns about the negative impact that alcohol 
can have on individuals and communities, licensing statutes 
generally include a right for community members to object 
to the grant of a new licence or a renewal of a licence. The 
National Community Action on Alcohol Network, convened 
and supported by the Alcohol Forum, was formed in early 
2017 to support community action on alcohol in Ireland 
and to facilitate collective working on issues of common 
concern. It approached the Public Interest Law Alliance 
(PILA) to develop a legal guide on the licensing process 
in Ireland, as it is recognised that there is a link between 
the licensing of alcohol and its consumption. The guide,1 
published in May 2017, was compiled amid growing concerns 
about the widespread availability of alcohol in communities. 
It is intended to be a practical guide to the when, where and 
how of objecting to a proposed grant or renewal of a licence.
Licence types
• An on-licence grants permission to sell intoxicating liquor 
for consumption either on or off the premises. Most 
current on-licences are full licences, that is, any type of 
alcohol may be sold during all permitted opening hours. 
• An occasional licence permits an existing on-licence 
holder to sell alcohol during a special event, from a place 
other than that to which their existing on-licence is 
attached (e.g. a bar might have a drinks tent at a festival 
or Christmas market). 
• An off-licence grants permission to sell intoxicating 
liquor for consumption off the premises. There are five 
types: spirit retailer’s off-licence; beer retailer’s off-
licence; wine retailer’s off-licence; sweets retailer’s off-
licence (sweets are products like mead); and the cider 
retailer’s off-licence. 
• A public dancing licence grants permission to premises 
to hold a public dance or other entertainment, but it 
does not entitle the holder to sell alcohol.
There are a number of ‘exemptions’ that may be obtained in 
order to allow a licensed premises to open during otherwise 
prohibited hours. Bars that wish to gain such exemptions to 
stay open late will almost certainly require a public dance 
licence in order to be granted the exemption. Exemptions 
cannot be objected to as such. Therefore, if you wish to 
object to the operation of a nightclub, you must object to 
the public dance licence.
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18 • Manner in which a premises has been conducted in the 
previous year: Any evidence that the premises has been 
conducted in a disorderly manner would be relevant to 
this ground (e.g. convictions for ‘after hours’ trading, 
permitting drunkenness on the premises, serving to 
drunken or underage persons, etc.).
Further information on the licensing process and how to 
object to the grant or renewal of a licence may be found in 
the full report.
Deirdre Mongan
1 National Community Action on Alcohol Network and  
Tracey S (2017) A community guide to alcohol licensing  
in Ireland. Letterkenny: Alcohol Forum.  
http://www.drugsandalcohol.ie/28432/ 
• The adequacy of the existing number of licensed 
premises of the same character in the neighbourhood: 
This relates to whether the existing number of licensed 
premises satisfies the existing level of demand for such 
premises. This will involve consideration of changes in 
volume of sales and changes in population.
• The number of previously licensed houses in the 
neighbourhood: This considers if the existing number 
of licensed premises in the area is sufficient to meet 
existing demand. The demand to be met must be existing 
demand; any projected increases in demand (e.g. due to 
development in the area) are not relevant.
Alcohol licensing in Ireland continued
Unintended 
consequences of 
drug control policies
The Pompidou Group of the Council of Europe has published 
a new report, Costs and unintended consequences of drug 
control policies.1 The overall aim of the report is to define 
and identify costs and unintended negative effects of 
drug control policies, borne by individuals and society (p. 
9). The findings are based on a wider study carried out by 
the Pompidou Group in cooperation with the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
In the previous issue of Drugnet Ireland,2 the findings of 
two reports on drug-related public expenditure were 
discussed.3,4 The first part of current report echoes many 
of the key findings reported in that article. It explores what 
drug-related public expenditure is, why it matters, and the 
methodological challenges faced in estimating its value. 
These are not repeated here; instead, this article focuses 
on the second part of the report — the unintended negative 
consequences of drug control policies.
Unintended negative consequences
The authors define unintended consequences as those ‘that 
are not deliberate or intentional; they are not the targeted 
effects of any given action’ (p. 9). These vary between 
countries: affected by, for example, the national drug 
legislation and its implementation, as well as the social and 
economic context, and the types of substances considered. 
The authors outline in detail the health and non-health (social 
and economic) consequences for both users and non-users 
of drugs (p. 10), as well as almost 40 ‘possible interventions’ 
to ameliorate these unintended (although not always 
unexpected) consequences. Below is a broad summary of the 
unintended consequences covered in this report.
Health-related consequences
Three broad categories of health-related consequences  
are identified:
• Effects from restricted availability of controlled 
medicines: One of ‘the most serious’ consequences 
of control policies for non-users of illegal drugs (p. 
46) is the unmet pain relief and palliative care needs 
of patients due to the strict enforcement of the UN 
conventions. For opioid-dependent users (p. 46), the 
strict controls mean the denial of access in some 
countries to the ‘most effective treatment’ for them, 
i.e. opioid substitution treatment (OST). More broadly, 
restricted access to marijuana has made it more difficult 
to conduct research on its medical use.
• Effects due to enforcement of drug prohibition: 
Four unintended consequences are identified in this 
category. First, people may switch to using more 
hazardous substances because they are ‘legal’. The 
authors argue that the health risks associated with the 
new psychoactive substances are unknown and they 
are often ‘dangerous and potentially lethal substances’ 
(p. 27). Second, because of the elevated price that 
comes as a result of a drug being prohibited, people can 
use them in a more cost-effective but riskier way. For 
example, they move from smoking to injecting heroin. 
Third, the variation in purity of substances available on 
the black market means an increased risk of mortality 
and morbidity for people who use. Finally, use of a 
prohibited substance tends to be stigmatised. This can 
discourage people from seeking help and support, can 
have a negative impact on their self-esteem and mental 
wellbeing, and may lead to healthcare providers having 
negative attitudes towards people who use.
• Effects from enforcement actions: First, where there are 
periods of intensified police activity to enforce drug laws, 
this can have a negative impact on attendance at services. 
This can, for example, increase the risk of the spread of 
drug-related infectious diseases, and make it less likely 
for people to contact emergency services when someone 
has overdosed. Second, where there is contact between 
the police and ‘suspects of drug law offenders’ (p. 32), 
the authors argue that there is a risk of inappropriate 
use of force, violation of rights, and physical and mental 
harm. Third, there can be barriers to providing appropriate 
services to those who are in detention. This can increase 
the risk of the spread of drug-related infectious diseases.
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Concluding comment
The authors conclude that to evaluate and improve drug 
policy, stakeholders need to know how much these policies 
are costing, and take into account all possible effects 
of the associated interventions and actions, including 
the unintended negative consequences. They also argue 
that many of these consequences are predictable and 
appropriate interventions should therefore be put in place  
to minimise their impact on people who use drugs and on 
wider society.
Lucy Dillon
1 Bretteville-Jensen AL, Mikulic S, Bem P, Papamalis F, Harel-Fisch 
Y, Sieroslawski J, et al. (EMCDDA) (2017) Costs and unintended 
consequences of drug control policies. Brussels: Council of 
Europe. http://www.drugsandalcohol.ie/28536/
2 Dillon L (2018) Exploring drug-related public expenditure.  
Drugnet Ireland, 64: 15—16.
3 Bretteville-Jensen AL, Costa Storti C, Kattau T, Mikulic S, 
Trigueiros F, Papamalis F, et al. (EMCDDA) (2017) Public 
expenditure on supply reduction policies. Brussels: Council  
of Europe. http://www.drugsandalcohol.ie/27458 
4 European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) (2017) Drug treatment expenditure: a methodological 
overview, EMCDDA Insights 24. Luxembourg: Publications Office 
of the European Union. http://www.drugsandalcohol.ie/28010/ 
Social and economic related consequences
Three broad categories of non-health-related effects are 
identified:
• Effects of high profit margins and price levels of 
illegal drugs: First, the high profit margins offered by 
the illegal drugs market attract and finance organised 
crime groups, including those involved with terrorism. 
It also encourages trafficking of people and other items 
through the same networks, as well as the associated 
corruption of officials. This all feeds into an environment 
characterised by ‘high levels of violence, criminal 
motivation and risk-taking’ (p. 36). Second, the high price 
levels associated with illegal drugs means that people 
commit acquisitive crime to finance their drug use.
• Effects of stigmatisation due to perceptions of people 
who use drugs as criminals: Feeling stigmatised can lead 
to low self-esteem and reduced motivation to engage in 
economic and social activity, and to access community 
life and services. The authors argue that it can 
exacerbate existing forms of discrimination and increase 
people’s readiness to get involved in illegal activities. The 
stigma associated with drug use can mean people who 
use drugs are at increased risk of arrest and pre-trial 
detention, when compared with people involved in some 
other criminal activities.
• Effects of criminal records and imprisonment for 
drug offences: First, having a criminal record limits a 
person’s future opportunities. As well as increasing the 
risk of stigmatisation and social exclusion, it can impact 
negatively on employment opportunities, access to 
housing, and access to education. Second, where people 
have been imprisoned for a period this can lead to 
‘shattered ties with individual social support networks’ 
(p. 41), an increase in the risk of reoffending, and 
increased exposure to violence.
Drug control policies continued
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18 • 90% of schools reported that they address the topics of 
‘awareness of and combating drug abuse’, ‘awareness of 
and combating alcohol abuse’ and ‘awareness of health 
risks of smoking’ with pupils. In addition, over 97% of 
schools reported that they addressed ‘resisting peer 
pressure’ and ‘making sound decisions’. These findings 
are all similar to 2012. 
• 56% of schools described substance misuse as 
challenging or very challenging to teach, while 44% 
reported that it was not challenging to teach. 
• 94% of schools used the Walk Tall4 programme to 
support teaching pupils about substance misuse. 
Twenty-two per cent used an external agency to help 
them to deliver their substance misuse programme. The 
main agencies used by primary schools were An Garda 
Síochána and the local drugs taskforce. 
The findings for post-primary schools were: 
• 95% of schools either had a substance misuse policy 
or were in the process of developing one. As with the 
primary schools, it is unclear from the report what 
percentage actually had an active policy. 
• 87% of schools had consulted parents in the development 
of their substance misuse policy, 13% had not. 
• All of the schools reported that they address the topics 
of ‘awareness of and combating drug abuse’, ‘awareness 
of and combating alcohol abuse’ and ‘awareness of 
health risks of smoking’ with pupils. 
• Three-quarters of schools reported using On My Own Two 
Feet4 to support them in their work in this area. 
• 56% of schools found it a challenging topic to teach; 
49% reported it as somewhat challenging, and 7% as very 
challenging. Forty-four per cent of schools reported that 
it was not challenging to teach. 
• 48% of schools reported bringing in external agencies to 
support the delivery of their work in this area. The main 
agencies used were An Garda Síochána and the Health 
Service Executive.
Concluding comment
In its introduction, the report is described as providing 
‘evidence of the very good work being undertaken by 
respondent schools/centres in helping their learners to 
develop the key skills and resilience necessary to cope with 
the many demands and pressures they face both within and 
outside their learning environment’ (p. 12). However, the 
methods used do not allow for any insights into the quality 
and effectiveness of, for example, the policies and what is 
being delivered to pupils. These are critical considerations 
when exploring schools’ delivery on addressing pupils’ needs 
in this area. 
RESPONSES 
Lifeskills 2015
The Lifeskills survey is carried out by the Department of 
Education and Skills in primary and post-primary schools.1 
Data have been collected in 2009, 2012, 2015 and a fourth 
round is expected to be carried out in 2018.2 The findings of 
the 2015 Lifeskills survey were published in July 2017.3
The survey
The Lifeskills survey focuses on skills being taught in schools 
that ‘are for life’ (p. 64), including physical activity and healthy 
eating; aspects of Social, Personal and Health Education 
(SPHE) and Relationships and Sexuality Education (RSE); 
anti-bullying; substance use; and road safety. In 2015, extra 
questions were added on: links between primary schools and 
early years’ settings; education for sustainable development; 
and, interaction with the entrepreneurial sector — both 
business and social. Survey questions focus on school 
policies, programme content and delivery. The findings are 
predominantly descriptive of outputs in the areas of interest 
(see Table 1). However, the survey attempts to deal with some 
more complex issues that may be beyond the scope of its 
design. For example, it asks ‘do students in your school know 
what to do, if bullied?’ with response options ‘yes/no’. While 
99% of post-primary schools responded ‘yes’ to this question, 
it is unclear what this assessment is based on (p. 22).
Lifeskills is an online survey of schools and participation 
is voluntary. It is unclear from the report who completes 
the survey and whether or not this is consistent between 
schools. However, the survey is described by the authors 
as representing the ‘perspective of the school community’ 
(p. 54). In 2015, there was a response rate of 53% from the 
primary schools, down from 68% in 2012; and, 33% from 
post-primary schools, down from 52% in 2012. In relation to 
the post-primary school response rate, the authors noted 
the drop in participation as ‘very significant and a concern 
for the Department’ (p. 28). 
Substance use
Substance use is one of the topics covered in the report. 
Schools were asked about whether a substance misuse 
policy was in place; whether parents contributed to its 
development; which topics were covered in related lessons; 
how challenging the school found it to teach in this area; and 
which outside agencies were involved in the delivery of work 
on this topic. 
The findings for primary schools were: 
• 88% of schools were either in the process of developing 
a policy or had one in place, while 12% had none. This 
is the same level as 2012. It is unclear from the report 
what proportion of the 88% of schools was only ‘in the 
process’ of developing a policy. 
• Of those schools that had a substance misuse policy in 
place, 66% reported that parents were consulted on the 
development of the policy. 
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Table 1: 2012 and 2015 Lifeskills survey results for primary and post-primary schools
Lifeskills survey Primary schools Post-primary schools
2012 2015 2012 2015
% response rate 68 53 52 33
Have substance misuse policy 88 88 93 95
Have healthy eating policy 88 92 37 32
Have RSE policy 87 94 77 87
Have student council/voice 14 21 97 99
Have sport outside school time 81 82 85 97
Have anti-bullying policy 98 99 99 99
Have road safety programme 98 100 84 93
Have Stay Safe programme 99 100 n/a n/a
Have Walk Tall programme 94 94 n/a n/a
Resisting peer pressure 99 97 n/a n/a
The food pyramid 99 99 n/a n/a
Part of health-promoting schools n/a n/a 37 63
Use Your Road to Safety programme n/a n/a 44 78
Encourage physical activity during breaks n/a n/a 86 89
Source: Department of Education and Skills, 2017, Table 1.1 and Table 1.2 (pp. 5, 7)2
Lifeskills 2015 continued
The authors identify a number of issues that need to be 
addressed to improve and support the delivery of lifeskills 
in the school environment. In relation to substance use, 
the focus is on providing staff with continued professional 
development to make the delivery of sessions ‘less 
challenging’. It is beyond the scope of the survey to reflect 
on the content and mode of delivery. However, some 
findings would suggest the need to explore further how 
the Department of Education and Skills can best facilitate 
schools in delivering programmes in line with the current 
evidence of best practice. For example, the finding that 
An Garda Síochána is involved in the delivery of classroom 
sessions on substance misuse in some schools is not in line 
with international best practice guidance.5
Lucy Dillon
1 In 2015, the Lifeskills survey was carried out in Youthreach 
Centres and Community Training Centres for the first time. The 
findings of this element of the report are not covered in this 
article. The report recommends that these centres develop 
and carry out their own version of the survey for the future to 
facilitate a more appropriate set of questions. 
2  Department of Education and Skills (2014) Results of the 
Department of Education and Skills ‘Lifeskills’ survey,  
2012. Dublin: Department of Education and Skills.  
http://www.drugsandalcohol.ie/21391/ 
3 Department of Education and Skills (2017) Lifeskills survey 2015. 
Report on survey findings. Dublin: Department of Education  
and Skills. http://www.drugsandalcohol.ie/28560/
4 The Walk Tall and the On My Own Two Feet programmes are 
substance misuse prevention programmes, which have been 
integrated into the national SPHE curriculum for primary and 
post-primary schools, respectively.
5 As reported on in an earlier issue of Drugnet Ireland,  
the United Nations Office on Drugs and Crime (UNODC)  
has found that programmes that use police officers to  
deliver classroom sessions have no or negative prevention 
outcomes. See Dillon L (2017) ‘What works’ in drug education  
and prevention? A review, Drugnet Ireland 61: 17—19.  
www.drugsandalcohol.ie/27211/1/Drugnet_61_final.pdf 
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18 In her address, Minister of State Catherine Byrne TD 
emphasised the valuable work of the NFSN, including the 
importance of the NFSN being involved in the consultation 
process for the new National Drugs Strategy. She also 
mentioned the role of naloxone in helping to prevent deaths 
from opiate overdose and the importance of expanding 
the availability of naloxone nationwide. She stressed her 
commitment as Minister of State to continue to highlight  
the impact of drug-related deaths and welcomed the  
health-led approach and actions on family support  
included in the new strategy. 
Hannah Rodriguez from UISCE, a forum for drug users in 
Dublin’s north inner city, highlighted the importance of UISCE 
being included in the consultation process for the latest 
National Drugs Strategy and welcomed the medical approach 
to supporting people who use drugs and the use of person-
first terminology. She acknowledged the work of the NFSN in 
helping to dissolve the stigma attached to people who use 
drugs and their families.
In his address, Archbishop Diarmuid Martin spoke of the 
current horror, violence, brutality and intimidation in 
the drug scene. He stressed the debt of society to NFSN 
members for their support and understanding to others  
in grief.
For many families, this service was the first time that 
they could openly grieve for loved ones lost to drug use 
and related causes. The volume of family support groups 
was evident, with support groups from across the island 
of Ireland represented at this year’s service. Personal 
testimonies were given by members of family support 
groups, reflecting the vital support received through these 
groups. These included Terry Byrne, a member of North Star 
Family Support Project, who highlighted the vital importance 
of peer support groups, members of which support each 
other and provide a sense of belonging in a welcoming non-
judgemental atmosphere with no stigma attached. 
Finally, Marian Davitt gave a heartfelt speech about her 
experience of grief after the death of her son and the 
invaluable support she received through the bereavement 
support group. She encouraged people to look for support.
The NFSN runs a 10-week bereavement programme twice a 
year and family members can contact the NFSN and avail of 
assistance from this group. 
Ena Lynn
1 The National Family Support Network can be contacted at 5 
Gardiner Row, Dublin 1 on 01 898 0148 or info@fsn.ie or online 
www.fsn.ie.
Nineteenth 
Annual Service of 
Commemoration  
and Hope
The National Family Support Network (NFSN)1 is an 
autonomous self-help organisation that provides support to 
families and respects the experiences of families affected 
by substance misuse in a welcoming non-judgemental 
atmosphere. On Thursday, 1 February 2018, the NFSN held 
its 19th Annual Service of Commemoration and Hope. 
This spiritual, multidenominational service is held in 
remembrance of loved ones lost to substance misuse and 
related causes and to publicly support and offer hope to 
families living with the devastation that substance misuse 
causes. Those in attendance included the Lord Mayor of 
Dublin, Mícheál Mac Donncha; Comdt Caroline Burke, aide-
de-camp to An Taoiseach; Archbishop Diarmuid Martin; 
Archbishop Michael Jackson; Bishop Eamonn Walsh; and 
other religious representatives, as well as family members, 
friends, and many people involved in substance misuse work. 
Music was provided by the soprano Nickola Hendy and the 
High Hopes Choir.
In her address to the gathering, Sadie Grace, coordinator of 
the NFSN, spoke directly to family members, stressing that 
they are not alone. She highlighted the latest report from the 
National Drug-Related Deaths Index (NDRDI), which showed 
that 695 deaths occurred in 2015 directly or indirectly due to 
drug use. The NFSN advocated strongly for accurate figures 
on drug-related deaths and, as a result, the NDRDI was 
established in 2005. However, she stressed the importance 
of more detailed research on the impact that drug-related 
deaths have on families left behind. She mentioned 
important research carried out by Prof Sharon Lambert 
in this area, which highlights the stigma and shame felt by 
family members. Sadie emphasised the positive impact that 
support services provide in helping family members deal 
with all aspects of bereavement, and encouraged family 
members to contact the NFSN and avail of assistance from 
the bereavement support group programme.
Sadie spoke about the impact of drug-related intimidation 
and the need for real action and leadership to respond to 
the high level of intimidation in Dublin’s north inner city. In 
her closing statement, she spoke of the NFSN’s resilience 
to continue to advocate on behalf of families who have 
lost their children to drug-related deaths, and called on 
stakeholders to ensure actions, including those outlined in 
the new drugs strategy, are put into practice.
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Recent publications
The following abstracts are cited from published journal articles 
recently added to the repository of the HRB National Drugs 
Library at www.drugsandalcohol.ie 
PREVALENCE AND CURRENT SITUATION
The associations among personality, alcohol-related  
Protective Behavioural Strategies (PBS), alcohol consumption 
and sexual intercourse in Irish, female college students
Moylett S and Hughes BM (2017) 
Addictive Behaviors Reports, 6: 56–64. 
http://www.drugsandalcohol.ie/28433/
The study presented one of the first examinations of the 
associations among personality, alcohol-related protective 
behavioural strategies (PBS), alcohol consumption, sexual 
intercourse and sex-related alcohol negative consequences in 
Irish, female college students (n=522).
The findings of this study posited that the use of PBS has a 
key role to play in the levels of sexual intercourse and alcohol 
consumption, age and openness, and the associated negative 
sexual consequences in Irish, female college students.
Self-harm among the homeless population in Ireland:  
A national registry-based study of incidence and  
associated factors
Barrett P, Griffin E, Corcoran P, O’Mahony M and Arensman E 
(2018) Journal of Affective Disorders, 229: 523–31. 
http://www.drugsandalcohol.ie/28457/ 
The study aim was to estimate the incidence of self-harm among 
the homeless population and to assess factors associated with 
self-harm.
There is a disproportionate burden of self-harm among the 
homeless. Targeted preventive actions are warranted.
Traumatic brain injury and co-occurring problems in prison 
populations: a systematic review
O’Rourke C, Linden MA, Lohan M and Bates-Gaston J (2016)  
Brain Injury, 30(7): 839–54. 
http://www.drugsandalcohol.ie/28446/ 
The aim of this review is to systematically explore the literature 
surrounding the rates of TBI and their co-occurrences in a prison 
population.
The high degree of variation in TBI rates may be attributed to 
the inconsistent way in which TBI was measured, with only seven 
studies using valid and reliable screening tools. Additionally, gaps 
in the literature surrounding personality outcomes in prisoners 
with TBI, female prisoners with TBI and qualitative outcomes 
were found.
Health and social problems associated with recent novel 
psychoactive substance (NPS) use amongst marginalised, 
nightlife and online users in six European countries 
Van Hout MC, Benschop A, Bujalski M, Dabrowska K,  
Demetrovics Z, Felvinczi K, et al. (2018) International Journal  
of Mental Health and Addiction, 16(2): 480–95.  
http://www.drugsandalcohol.ie/28500/
This study describes health and social consequences of recent 
NPS use as reported in a survey of marginalised, nightlife and 
online NPS users in the Netherlands, Hungary, Portugal, Ireland, 
Germany and Poland (n=3023).
Marginalised users reported substantially more acute side 
effects, more mid- and long-term mental and physical problems, 
and more social problems. Development of country-specific NPS 
awareness raising initiatives, health and social service needs 
assessments, and targeted responses are warranted.
Intentional drug overdose involving pregabalin and  
gabapentin: findings from the National Self-Harm Registry 
Ireland, 2007—2015
Daly C, Griffin E, Ashcroft DM, Webb RT, Perry IJ and Arensman E 
(2017) Clinical Drug Investigation, 38(4): 373–80.  
http://www.drugsandalcohol.ie/28436/ 
This paper examines the trends in the prevalence of 
gabapentinoids taken in Intentional drug overdose (IDO), the 
profile of individuals taking them, and associated overdose 
characteristics.
It is important for clinicians to exercise vigilance while 
prescribing gabapentinoids, including being aware of other 
medications that their patients may have access to. Our findings 
support the need for routine monitoring for signs of misuse 
among those prescribed gabapentinoids.
National Drugs Library
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A high prevalence rate of a positive 
screen for cognitive impairment in 
patients with Human Immunodeficiency 
Virus attending an Irish clinic
McNamara PH, Coen R, Redmond J, 
Doherty CP and Bergin C (2017) Open 
Forum Infectious Diseases, 4(1): ofw242. 
http://www.drugsandalcohol.ie/28177/ 
Human immunodeficiency virus (HIV)-
associated neurocognitive disorders 
occur in 20%—50% of HIV-positive 
patients. We undertook this study to 
assess the prevalence of a positive 
screen for cognitive impairment in 
the clinic population at our institution 
and to demonstrate the feasibility of 
implementing a screening program in 
routine clinical encounters.
The study highlights the necessity 
for a structured, prospective, large-
scale screening program for cognitive 
impairment across countries with 
limited resources and demonstrates the 
feasibility of easily implementing this with 
minimal training.
Different drinking motives, different 
adverse consequences? Evidence among 
adolescents from 10 European countries  
Wicki M, Kuntsche E, Eichenberger Y, 
Aasvee K, Bendtsen P, Dankulincová 
Vselská Z, et al. (2017) Drug and Alcohol 
Review, 36(6): 731–41. 
http://www.drugsandalcohol.ie/28172/ 
This study, which builds on previous 
research demonstrating that drinking 
motives are associated with adverse 
consequences, investigates the 
associations between drinking motives 
and non-alcohol-attributed adverse 
consequences and disentangles alcohol-
related and direct effects.
While the actual mean level of drinking 
motives, alcohol use and adverse 
consequence varied across countries, 
the consistency of association patterns 
implies that drinking motive-inspired 
health promotion efforts are likely to 
be beneficial across Europe. This is 
particularly important for coping drinkers 
because they are especially prone to 
adverse consequences over and above 
their alcohol use.
Alcohol consumption among first- and 
second-generation immigrant and native 
adolescents in 23 countries: testing 
the importance of origin and receiving 
country alcohol prevalence rates
Barsties LS, Walsh SD, Huijts T, Bendtsen 
P, Molcho M, Buijs T, et al. (2017) Drug and 
Alcohol Review, 36(6): 769–78. 
http://www.drugsandalcohol.ie/28171/ 
This internationally comparative 
study examines differences in alcohol 
consumption between first- and 
second-generation immigrant and 
native adolescents. We also investigate 
to what extent origin and receiving 
country alcohol per capita consumption 
(APCC) rates and proportions of heavy 
episodic drinkers (HED) are associated 
with immigrant adolescents’ alcohol 
consumption.
Our results suggest differences in 
lifetime frequencies of alcohol use 
and drunkenness between natives and 
first- and second-generation immigrant 
adolescents. Origin country APCC 
and HED seem to affect immigrant 
adolescents' alcohol consumption 
differently than receiving country  
APCC and HED.
Cross-section and panel estimates of 
peer effects in early adolescent cannabis 
use: with a little help from my 'friends 
once removed'
Moriarty J, McVicar D and Higgins K (2016) 
Social Science & Medicine, 163: 37–44. 
http://www.drugsandalcohol.ie/28397/ 
Peer effects in adolescent cannabis are 
difficult to estimate, due in part to the 
lack of appropriate data on behaviour  
and social ties. This paper exploits survey 
data that have many desirable properties 
and have not previously been used for 
this purpose. 
We conclude that cross-sectional data 
can be used to estimate plausible positive 
peer effects on cannabis use where 
network structure information is available 
and appropriately exploited.
Alcohol involvement in suicide  
and self-harm 
Larkin C, Griffin E, Corcoran P, McAuliffe 
C, Perry IJ and Arensman E (2017)  
Crisis, 38(6): 413–22. 
http://www.drugsandalcohol.ie/28375/
This study sought to identify factors 
associated with alcohol consumption in 
cases of suicide and nonfatal self-harm 
presentations.
Alcohol consumption commonly precedes 
suicidal behavior, and several factors 
differentiated alcohol-related suicidal 
acts. Self-harm cases, in particular, differ 
in profile when alcohol is consumed and 
may require a tailored clinical approach 
to minimize risk of further nonfatal or 
fatal self-harm.
Mental health difficulties and suicidal 
behaviours among young migrants: 
multicentre study of European 
adolescents
McMahon EM, Corcoran P, Keeley H, 
Cannon M, Carli V, Wasserman C, et al. 
(2017) BJPsych Open, 3(6): 291–99.  
http://www.drugsandalcohol.ie/28369/
This study aims to examine the prevalence 
of emotional and behavioural difficulties, 
suicidal ideation and suicide attempts 
among migrant adolescents and their 
non-migrant peers.
Appropriate mental health services and 
school-based supports are required 
to meet the complex needs of migrant 
adolescents.
Risky sex behaviours among college 
students: the psychosocial profile
Dolphin L, Fitzgerald A and Dooley B 
(2017) Early Intervention in Psychiatry. 
Early online. 
http://www.drugsandalcohol.ie/28353/
Risky sex behaviours among college 
students are a growing public health 
concern. However, few studies have 
profiled these behaviours using a large 
range of psychosocial correlates.
Suggestions are made for sexual 
education and intervention programs 
to specifically target subgroups of the 
student population.
Chemsex, risk behaviours and sexually 
transmitted infections among men who 
have sex with men in Dublin, Ireland 
Glynn RW, Byrne N, O’Dea S, Shanley 
A, Codd M, Keenan E, et al. (2017) 
International Journal of Drug Policy,  
52: 9–15. 
http://www.drugsandalcohol.ie/28327/ 
This study aimed to assess the prevalence 
of chemsex, associated behaviours and 
STIs among attendees at Ireland's only 
MSM-specific sexual health clinic in Dublin 
over a six week period in 2016.
These results support international 
evidence of a chemsex culture among 
a subset of MSM. They will be used to 
develop an effective response which 
simultaneously addresses addiction 
and sexual ill-health among MSM 
who experience harm/seek help as a 
consequence of engagement in chemsex.
Recent publications continued
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Awareness of medical fitness to drive 
guidelines among occupational physicians 
and psychiatrists
Ryan M, McFadden R, Gilvarry E, Loane R, 
Whelan D and O’Neill D (2017)  
Irish Medical Journal, 110(10). 
http://www.drugsandalcohol.ie/28335/
Irrespective of national guidelines for 
medical fitness to drive, this study 
investigated the cumulative expert wisdom 
of clinicians regarding minimum periods 
of driving cessation required for patients 
suffering from conditions that can impair 
driver capability. Occupational Physicians 
(196) and Psychiatrists (103) completed an 
online questionnaire. 
Chi-square test results indicated 
statistically significant differences in clinical 
opinion between Occupational Physicians 
and Psychiatrists regarding driving 
cessation times for drivers suffering from 
psychiatric and alcohol misuse conditions 
except for alcohol dependence. Further 
studies are warranted to investigate these 
issues in more depth.
Usage of unscheduled hospital care by 
homeless individuals in Dublin, Ireland:  
a cross-sectional study
Ní Cheallaigh C, Cullivan S, Sears J,  
Lawlee AM, Browne J, Kieran J, et al. (2017) 
BMJ Open, 7(11): e016420.  
http://www.drugsandalcohol.ie/28307/
We sought to compare the use of 
unscheduled emergency department (ED) 
and inpatient care between housed and 
homeless hospital patients in a high-
income European setting in Dublin, Ireland.
Homeless patients represent a significant 
proportion of ED attendees and medical 
inpatients. In contrast to housed patients, 
the bulk of usage of unscheduled care by 
homeless people occurs in individuals aged 
25—65 years.
Neuroimaging of chronic alcohol misuse
Logan C, Asadi H, Kok HK, Looby ST, 
Brennan P, O’Hare A, et al. (2017) Journal 
of Medical Imaging and Radiation 
Oncology, 61(4): 435–40. 
http://www.drugsandalcohol.ie/28292/
Alcohol is one of the most commonly 
abused substances worldwide. It results 
in a wide range of diseases and disorders 
affecting many organ systems. Alcohol-
related nutritional deficiencies and 
electrolyte disturbance leave chronic 
abusers at risk of a range of demyelinating 
conditions to which the radiologist and 
clinician should always be alert. 
We present an educational review of these 
entities in terms of their clinical features, 
neuropathology and imaging features along 
with a case example of each condition.
A national survey of online gambling 
behaviours
Columb D and O’Gara C (2017)  
Irish Journal of Psychological Medicine. 
Early online. 
http://www.drugsandalcohol.ie/28197/ 
The aim of this study is to look at an 
Irish population in relation to the online 
gambling activities people are engaging 
with, the reasons for gambling online, 
their attitudes to online gambling and the 
financial/mental health consequences of 
online gambling.
Online gamblers in Ireland share similar 
behavioural profiles to online gamblers in 
the United Kingdom and worldwide. The 
majority of participants in this research 
have been adversely affected from both 
a mental and financial perspective due to 
their gambling behaviours.
Shared and divergent neural reactivity to 
non-drug operant response outcomes in 
current smokers and ex-smokers
Nestor LJ, McCabe E, Jones J, Clancy 
L and Garavan H (2018) Brain Research, 
1680: 54–61. 
http://www.drugsandalcohol.ie/28368/ 
The present study set out to examine the 
neural correlates of operant response 
outcomes in current smokers, ex-smokers 
and matched controls using a monetary 
incentive delay task during functional MRI. 
The results suggest a pattern of shared 
and divergent reactivity in current 
smokers and ex-smokers within 
corticolimbic regions that track both 
positive and negative operant response 
outcomes. Exaggerated adaptive 
processing in ex-smokers may promote 
long-term smoking cessation through 
amplified negative valence outcome 
monitoring.
RESPONSES
The ‘manageability of risk’ and recall 
on Supervised Licence: post-release 
pathways for serious violent and sexual 
offenders in Northern Ireland
Delimata A and Seymour M (2017)  
Irish Probation Journal, 14: 92–111. 
http://www.drugsandalcohol.ie/28165/ 
Extended custodial sentences (ECSs) for 
serious offenders were introduced under 
the Criminal Justice (Northern Ireland) 
Order 2008. These sentences combine 
custody with a subsequent period on 
supervised licence in the community 
during which offenders can be recalled to 
prison should their ‘risk of serious harm’ 
increase to an ‘unmanageable level’. 
Using a documentary file analysis 
approach, the study investigates the 
outcomes for all ECS offenders released 
under supervised licence between 15 
October 2010 and 31 December 2013  
(n=57).
The paper offers tentative observations 
as to why some offenders remained under 
licence in the community and others were 
recalled to custody. Analysis points to 
the potential of enhancing pre-release 
working relationships between offenders 
and supervisors, strengthening through-
care supports to reflect the complexity 
of offenders’ needs, and focusing on 
the integration of strengths-based 
approaches in risk management policy 
and practice.
Tackling a silent killer through screening
Robinson E, Thornton L and Migone C 
(2017) Forum, 34(11): 46–48. 
http://www.drugsandalcohol.ie/28341/
In Ireland there are between 20,100 and 
42,000 people with HCV infection, 60% 
of whom are as yet undiagnosed. 
New national clinical guidelines on 
hepatitis C screening was developed to 
make recommendations on who should 
be screened for HCV and how that 
screening should be done.
Pre-sentence reports and individualised 
justice: consistency, temporality and 
contingency
Carr N and Maguire N (2017)  
Irish Probation Journal, 14: 52–71. 
http://www.drugsandalcohol.ie/28303/ 
The research was commissioned by 
the Probation Service and was a small-
scale, in-depth study exploring the 
role of PSRs (pre-sentence reports) in 
sentencing, with a particular emphasis 
on understanding the process of 
communication involved from the 
perspectives of Probation Officers who 
create the reports and judges who 
request and receive them.
This paper draws on the findings from the 
research to explore specific aspects of 
the use of PSRs. It begins by highlighting 
certain features of the Irish context 
and then provides a brief overview of 
the methodological approach before 
presenting a summary of selected findings, 
including those relating to the purpose 
of reports and variation in their use. We 
explore some of the key themes arising 
from the research, including consistency, 
temporality and contingency. We conclude 
by noting the potential positives of pausing 
a process, but highlight the need for 
greater consistency to ensure equitable 
access across the country.
Recent publications continued
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Recent publications continued
Overview of a group work programme: 
the choices and the challenges
Clarke N (2017) Irish Probation Journal, 
14: 151–63. 
http://www.drugsandalcohol.ie/28305/ 
The ‘Nothing Works’ and ‘What Works’ 
debates were central to discourse on 
recidivism in the 1970s and 1980s. When 
the outrage subsided and the research 
based on meta-analysis was reviewed, 
one simple message for practitioners 
emerged: some things work with some 
people some of the time. The challenge 
is to find the right intervention for the 
right person at the right time. As agents 
of change, no practitioner can afford to 
be a ‘one-trick pony’ but will draw from 
a toolkit of interventions to address 
the factors that contribute to offending 
behaviour. 
Programme interventions, specifically 
CBT-based group work programmes, are 
recognised as providing an appropriate 
and structured environment in which 
to address pro-criminal thinking and 
attitudes in order to achieve reduced 
offending and ultimately desistance and 
reintegration into communities. The 
Probation Service Strategy 2011—2014 
identified the introduction of a range of 
programmes to enhance and support 
effective practice as a key goal. The 
Choice and Challenge Group Programme 
was the Service’s first nationally approved 
offending behaviour programme. 
Developed in accordance with evidence-
based principles, its central focus 
is to challenge negative beliefs and 
attitudes, promote prosocial behaviours 
and enhance individual capacity for 
problem-solving and personal growth and 
development. This is a narrative about its 
implementation.
An evaluation of practitioner's 
experience of service users seeking 
community detoxification from 
benzodiazepines
Wall M, Lambert S and Horan A (2017) 
Journal of Psychoactive Drugs.  
Early online. 
http://www.drugsandalcohol.ie/28286/ 
The purpose of this study is to identify 
the issues highlighted in the data and 
consequently inform policy development, 
service delivery, future training, and 
pathways to support service users (SUs). 
Findings indicate that, while practitioners 
had high levels of confidence in 
managing community-based detoxes, 
levels of knowledge of schedules, 
contraindications, access to support, 
and appropriate referral pathways were 
limited. Barriers to supporting detoxes 
emerged, emphasizing the importance 
of multidisciplinary and interagency care 
planning. Changing trends in drug use 
led participants to indicate a need for 
pharmacology training and development 
of specific local protocols.
Opiate use disorders and overdose: 
medical students’ experiences, 
satisfaction with learning, and attitudes 
toward community naloxone provision
Tobin H, Klimas J, Barry T, Egan M  
and Bury G (2017) Addictive Behaviors. 
Early online. 
http://www.drugsandalcohol.ie/28290/
We examined final-year medical students’ 
learning experiences and attitudes 
toward opioid use disorder, overdose 
and community naloxone provision as an 
emerging overdose treatment.
Our findings suggest an unmet learning 
need in undergraduate training on 
opioid use disorder, with potential 
consequences for patient care.
A multi-faceted intervention to reduce 
alcohol misuse and harm amongst sports 
people in Ireland: a controlled trial
O’Farrell A, Kingsland M, Kenny S, Eldin N, 
Wiggers J, Wolfenden L, et al. (2018)  
Drug and Alcohol Review, 37(1): 14–22. 
http://www.drugsandalcohol.ie/28266/
The study aimed to test the effectiveness 
of an intervention to reduce alcohol 
misuse and related harms amongst 
amateur sports people in Ireland.
Intervention in community sports clubs 
may be effective in reducing the number 
of alcohol-related harms. Low levels of 
intervention participation and inadequate 
intervention dose are possible reasons for 
lack of a broader intervention effect.
Motivations for reducing alcohol 
consumption: an international survey 
exploring experiences that may lead to a 
change in drinking habits
Davies EL, Conroy D, Winstock AR  
and Ferris J (2017) Addictive Behaviors,  
75: 40–46. 
http://www.drugsandalcohol.ie/28277/ 
The aim of the current paper was to 
explore the experiences that might 
lead people to reduce their alcohol 
consumption and to compare these 
findings between respondents from 21 
different countries.
Understanding the different motivations 
that may lead individuals to change their 
drinking behaviours can be used to inform 
targeted brief interventions and targeted 
public health guidance.
POLICY
Alcohol control policies and alcohol 
consumption: an international 
comparison of 167 countries
Madureira-Lima J and Galea S (2018) 
Journal of Epidemiology & Community 
Health, 72(1): 54–60. 
http://www.drugsandalcohol.ie/28342/
Alcohol control policy has a fundamental 
role in limiting negative health, 
economic and social harm caused by 
alcohol consumption. However, there is 
substantial international heterogeneity 
in country-level policy adoption, 
implementation and monitoring. 
Comparative measures so far focused on 
Europe or the Organisation for Economic 
Co-operation and Development 
countries.
ACPI offers a measure of alcohol control 
policy across countries that makes use 
of a larger number of countries than its 
predecessors, as well as a wider range 
of methodologies for its calculation, 
both of which contribute to its validity. 
Furthermore, it shows that the statutory 
strictness of alcohol control policies is 
associated with lower levels of alcohol 
consumption.
